SVM-light Version V5.01-TK-1.5
5 # kernel type
3 # kernel parameter -d 
1 # kernel parameter -g 
1 # kernel parameter -s 
1 # kernel parameter -r 
empty# kernel parameter -u 
0.4 # kernel parameter -L 
1 # kernel parameter -T 
S # kernel parameter -C 
1 # kernel parameter -F 
0 # kernel parameter -S 
0.400000 # kernel parameter -M 
3 # kernel parameter -N 
S # kernel parameter -V 
S # kernel parameter -W 
0 # kernel parameter -U 
1912 # highest feature index 
300 # number of training documents 
212 # number of support vectors plus 1 
0.97633252 # threshold b, each following line is a SV (starting with alpha*y)
-4.6457201581691007774566060106736  |BT| (S (PP (IN (In))(NP (JJ (current))(NN (study))))(, (,))(VP (VBD (found))(S (S (NP (NN (EREG))(JJ (overexpressed))(NNS (NSCLCs)))(VP (VBG (harboring))(NP (NNP (KRAS)))))(, (,))(NP (NNP (BRAF))(NN (EGFR))(NN (mutation)))(VP (VBN (compared))(NP (NNS (NSCLCs))(JJ (wild-type))(NN (KRAS/BRAF/EGFR))))))) |ET|  |BS| 18:G05.365.590 110:C04.588.894.797.520.109.220.249 278:D08.811.913.696.620.682.700.559.842.374 388:G05.360.340.024.340.375.500.791.550  |ES| 2:1 8:1 19:1 25:1 34:1 37:1 50:1 131:1 175:1 187:1 244:1 958:1 1137:1 1303:1 1304:1 1305:1 1306:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (Notch-1))(NN (Notch-4))(JJ (potent))(NN (breast))(NN (oncogene)))(VP (VBN (overexpressed))(NP (JJ (triple-negative))(NNS (subtypes))(NN (breast))(NN (cancer))))) |ET|  |BS| 9:G05.360.340.024.340.375.500 10:A01.236  |ES| 18:1 19:1 20:1 21:1 22:1 23:1 24:1 25:1 26:1 27:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (JJ (Differential))(NN (effect))(JJ (oncogenic))(NN (K-Ras))(NN (N-Ras))(NN (proliferation)))(, (,))(NP (NN (differentiation))(NN (tumor))(NN (progression))(NN (colon)))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 16:C23.550.291.656 51:C04.588.274.476.411.307.180 74:G04.299.151 279:D27.888.569.100  |ES| 2:1 7:1 13:1 19:1 48:1 75:1 113:1 215:1 299:1 953:1 1905:1 1906:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (ADVP (RB (Furthermore)))(, (,))(NP (NP (JJ (stable))(NN (overexpression)))(VP (VBG (using))(NP (JJ (lentiviral))(NN (vector))(NN (NCI-H460))(NN (A549))(NN (cell)))))(VP (VBD (inhibited))(NP (NN (tumor))(NN (xenograft))(NN (growth))(JJ (immunodeficient))(NN (mouse)))(PRN (-LRB- (-LRB-))(NP (NP (CD (95))(ADJP (CD (50))(NN (%)))(NN (reduction)))(VP (VBN (compared))(NP (NN (control)))(, (,))(ADVP (RB (respectively)))(-RRB- (-RRB-))))(, (,))(PP (IN (whereas))(NP (NP (NP (NN (effect))(NN (mir-660))(NN (overexpression))(JJ (absent))(NN (H1299)))(, (,))(NP (NP (NN (lung))(NN (cancer))(NN (cell))(NN (line)))(VP (VBG (lacking))(NP (NN (p53))(NN (locus))))))(, (,))(NP (ADJP (FW (vitro))(FW (vivo)))(NN (assay)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 8:C04 11:B01.050.150.900.649.865.635.505.500 41:A11 45:G07.700.320.249 92:E04.936.764 93:A01.941.875 94:A11.251.210 106:E05.091 120:I01.409.418.750.600.480.150 121:B04.820.650.589 122:C14.280.383 123:G05.360.337 124:C20.673  |ES| 2:1 7:1 10:1 12:1 14:1 18:1 19:1 50:1 52:1 75:1 94:1 102:1 152:1 216:1 264:1 265:1 289:1 310:1 328:1 334:1 350:1 360:1 361:1 362:1 363:1 364:1 365:1 366:1 367:1 368:1 369:1 370:1 371:1 372:1 373:1 374:1 375:1 376:1 377:1 378:1  |EV| 
-2.8864881494698693131795153021812  |BT| (S (ADVP (NP (CD (One))(NN (year)))(RB (later)))(, (,))(NP (JJ (intra-abdominal))(JJ (metastatic))(NN (tumor)))(VP (VBD (detected))(ADJP (JJ (resected))))) |ET|  |BS| 8:C04 9:G05.360.340.024.340.375.500 25:G02.111.570.080 26:G02.111.570.080 27:G02.111.570.080 30:Z01.058.290.190.800 31:D08.811.520.224.800 98:A10 113:C04.697.650 143:E01.370.225.500.607.512 158:D23.101 198:D13.444.308 303:C04.557.450.795 372:G05.360.340.024.340.137.232 423:A01.923.047.025 424:L01.143.506.423.557 425:G01.358.500.505.650 426:E01.370.350.515 427:C04.588.033 428:D27.720.233  |ES| 2:1 7:1 9:1 19:1 68:1 118:1 127:1 272:1 337:1 344:1 534:1 654:1 666:1 806:1 833:1 965:1 1007:1 1021:1 1055:1 1250:1 1255:1 1327:1 1400:1 1452:1 1453:1 1454:1 1455:1 1456:1 1457:1 1458:1 1459:1 1460:1 1461:1 1462:1 1463:1 1464:1 1465:1 1466:1 1467:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (JJ (Chromosomal))(NN (analysis)))(VP (VBD (revealed))(SBAR (S (NP (NP (JJ (close))(JJ (genetic))(NN (relationship))(NN (papillary))(JJ (urothelial))(JJ (choriocarcinomatous))(NN (tumor))(NN (component)))(, (,))(VP (VBG (documenting))(NP (JJ (first))(NN (time))(NN (choriocarcinoma))(JJ (renal))(NN (pelvis)))))(VP (VBP (result))(NP (JJ (clonal))(NN (evolution))(JJ (urothelial))(NN (carcinoma))(NN (acquisition))(JJ (trophoblastic))(NN (differentiation)))))))) |ET|  |BS| 8:C04 74:G04.299.151 149:G05.360.340.024.340.364.875.890 289:A11.284.187 316:C04.557.465.955.207 317:C04.557.470.200.430 318:A05.810.453.537 319:A11.382.992 320:G04.299.350 321:A10.272.850 322:G01.910  |ES| 2:1 7:1 19:1 101:1 215:1 223:1 275:1 304:1 661:1 816:1 864:1 922:1 1021:1 1069:1 1075:1 1076:1 1077:1 1078:1 1079:1 1080:1 1081:1 1082:1 1083:1 1084:1 1085:1 1086:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (S (NP (NN (miR-137))(NN (overexpression)))(VP (VBD (resulted))(NP (NP (NN (downregulation))(NN (CAR))(NN (protein))(NN (mRNA)))(PRN (-LRB- (-LRB-))(PP (IN (via))(NP (NN (mRNA))(NN (degradation))))(-RRB- (-RRB-))))))(: (;))(S (VBN (sensitized))(NP (JJ (doxorubicin-resistant))(NN (cell))(NN (doxorubicin)))(-LRB- (-LRB-))(VP (VP (VBN (shown))(S (VP (VBN (reduced))(NP (NN (proliferation))))))(, (,))(VP (VBD (increased))(NP (NN (apoptosis))))(VP (VBD (increased))(NP (JJ (G2-phase))(NN (cell))(NN (cycle))(NN (arrest))))(SINV (-RRB- (-RRB-))(NP (VBD (reduced))(FW (vivo))(NN (growth))(NN (rate))(NN (neuroblastoma))(NN (xenograft))))))) |ET|  |BS| 7:D12.776 39:G04.299.139.160 41:A11 45:G07.700.320.249 85:G02.111.087.225 92:E04.936.764 93:A01.941.875 111:D13.444.735.544 136:D02.455.426.559.847.562.050.200.175 137:C04.557.465.625.600.590.650.550 139:J01.937.500.100 177:G04.299.134.109.500 178:G02.111.780  |ES| 2:1 4:1 10:1 14:1 19:1 41:1 47:1 89:1 94:1 102:1 152:1 217:1 237:1 265:1 299:1 325:1 378:1 420:1 421:1 423:1 424:1 452:1 594:1 595:1 596:1 597:1 598:1 599:1 600:1 601:1 602:1  |EV| 
-2.375072262450999005523044615984  |BT| (NP (NP (NN (CONCLUSION)))(: (:))(S (NP (DT (The))(NN (outcome))(NN (study)))(VP (VBP (represent))(NP (JJ (significant))(NN (contribution))(JJ (current))(NN (understanding))(JJ (preventive))(NN (mechanism))(NN (quercetin))(JJ (early))(NN (stage))(NN (liver))(NN (cancer))(NN (development)))(, (,))(S (VP (VBG (demonstrating))(NP (NP (NN (addition)))(VP (VBN (known))(VP (JJ (proapoptotic))(ADJP (ADJP (JJ (characteristic)))(, (,))(SBAR (S (NP (NN (flavonoid)))(VP (VBZ (modulates))(NP (NP (NN (expression))(JJ (critical))(NN (cell))(NN (cycle))(NN (regulator)))(NN (peroxisome))(NN (proliferator))(VBD (activated))(NN (receptor-alpha))(NN (activity))))))))))))))) |ET|  |BS| 239:F02.463.188.357 242:A03.620 353:G04.299.134 473:E01.789.625 533:D03.383.663.283.266.450.284.777 534:D03.383.663.283.266.450 535:H01.770.644.145.431 536:D12.776.826.239.500  |ES| 2:1 18:1 19:1 35:1 94:1 104:1 115:1 131:1 135:1 162:1 163:1 175:1 235:1 336:1 399:1 468:1 527:1 547:1 556:1 601:1 606:1 691:1 799:1 825:1 836:1 905:1 1128:1 1129:1 1360:1 1882:1 1883:1 1884:1 1885:1 1886:1 1887:1 1888:1 1889:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (ADVP (RB (Herein)))(, (,))(VP (VBP (show))(SBAR (S (NP (NNP (NANOG)))(VP (VBD (expressed))(NP (NP (NN (NANOG1))(NN (NANOGP8))(JJ (human))(JJ (colorectal))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (CRC)))(-RRB- (-RRB-))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 55:B01.050.150.900.649.801.400.112.400.400  |ES| 2:1 6:1 10:1 14:1 17:1 18:1 19:1 36:1 245:1 428:1 429:1 430:1 431:1 432:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (ADJP (RB (Here))(VBN (studied)))(NN (role))(NN (HNF4alpha))(NN (mechanism))(NN (deregulation))(NN (Cdx2))(NN (colon))(NN (cancer)))) |ET|  |BS| 15:F01.829.316.616  |ES| 18:1 19:1 31:1 113:1 123:1 162:1 213:1 400:1 401:1 402:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (Chemokine))(NN (gene))(NN (expression))(JJ (clonal))(NN (analysis))(NN (B))(NN (cell))(NN (tissue)))(VP (VBN (involved))(NP (JJ (lymphoid))(JJ (interstitial))(NN (pneumonitis))(JJ (HIV-infected))(JJ (pediatric))(NN (patient))))) |ET|  |BS| 50:M01.643 98:A10 155:G05.355.310 301:A11.251.353 310:A11.063.438 311:B04.820.650.589.650.350 312:C02.782.815.616.400.500 313:D12.644.276.374.200 314:C02.782.815.616.400 315:H02.403.670  |ES| 9:1 19:1 94:1 115:1 120:1 272:1 661:1 763:1 774:1 1068:1 1069:1 1070:1 1071:1 1072:1 1073:1 1074:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NN (Characterization))(JJ (tumor-suppressive))(NN (function))(NN (SOX6))(JJ (human))(NN (esophageal))(JJ (squamous))(NN (cell))(NN (carcinoma)))) |ET|  |BS| 8:C04 55:B01.050.150.900.649.801.400.112.400.400  |ES| 19:1 33:1 36:1 94:1 177:1 304:1 1064:1 1065:1 1066:1 1067:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NP (ADJP (RB (Little))(VBN (known)))(JJ (biological))(NN (significance))(NN (ELK1)))(, (,))(NP (JJ (transcriptional))(NN (factor))))(VP (VBZ (activates))(NP (NP (JJ (downstream))(NN (target)))(PP (VBG (including))(NP (NP (NN (c-fos))(NN (proto-oncogene)))(, (,))(NP (NN (bladder))(NN (cancer)))))))) |ET|  |BS| 165:G05.360.340.024.340.375.500.791.330 166:D12.776.930 167:H01.158.273  |ES| 2:1 18:1 19:1 160:1 185:1 301:1 440:1 555:1 556:1 557:1 558:1 559:1 560:1 561:1 562:1 563:1 564:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NP (NP (NN (MicroRNA-122)))(PRN (-LRB- (-LRB-))(NP (NN (miR-122)))(-RRB- (-RRB-))))(, (,))(NP (ADJP (RB (highly))(JJ (abundant)))(JJ (liver-specific))(NN (miRNA)))(, (,)))(VP (VBP (act))(NP (NP (NN (tumor))(NN (suppressor))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-)))))) |ET|  |BS| 81:E02.095.465.425.400.330.050.400 104:C04.557.470.200.025.255 184:D13.150.650.319 206:G05.360.340.024.340.375.249 242:A03.620  |ES| 2:1 7:1 10:1 14:1 19:1 246:1 303:1 304:1 441:1 626:1 700:1 840:1 1789:1 1797:1 1798:1 1799:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (PP (IN (Through))(NP (NN (combination))(NNS (data))(NN (mining))(JJ (biochemical))(NN (assay))))(, (,))(VP (VBD (identified))(NP (NP (NN (trophinin)))(, (,))(VP (MD (could))(VP (VB (enhance))(NP (NP (NN (cell))(NN (invasion)))(, (,))(NP (NP (JJ (novel))(JJ (prognostic))(NN (factor)))(JJ (early))(NN (stage))(NN (lung))(NN (cancer))))))))) |ET|  |BS| 41:A11 106:E05.091 182:A04.411 259:D12.776.395.240.150.500 472:L01.313.500.750.280.199 473:E01.789.625  |ES| 2:1 18:1 19:1 94:1 185:1 310:1 328:1 530:1 620:1 623:1 793:1 884:1 891:1 908:1 1128:1 1129:1 1266:1 1687:1 1688:1 1689:1 1690:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (VP (NN (DCAMKL-1))(NP (JJ (negative))(NN (regulator))(NN (let-7a))(NN (miRNA))(NN (biogenesis))(JJ (intestinal))(NN (stem))(JJ (colorectal))(NN (cancer))(NN (cell)))))(: (;)))(VP (MD (could))(VP (VB (represent))(NP (JJ (novel))(NN (target))(JJ (anti-cancer))(NN (stem))(JJ (cell-based))(NN (strategy)))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 20:G03.495 41:A11 47:A03.556.124 184:D13.150.650.319 259:D12.776.395.240.150.500 309:A18.024.937 331:G16.595 332:A11.872.650 333:D01.045  |ES| 17:1 18:1 19:1 94:1 104:1 109:1 160:1 217:1 235:1 239:1 449:1 799:1 840:1 891:1 908:1 1106:1 1109:1 1110:1 1111:1 1112:1 1113:1 1114:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NP (NN (Detection)))(VP (VBN (methylated))(NP (NN (TBX5)))))(VP (MD (may))(VP (VB (serve))(NP (JJ (potential))(NN (biomarker))(NN (prognosis))(NN (malignancy)))))) |ET|  |BS| 36:G02.111.087.029.538 158:D23.101 163:E01.789  |ES| 19:1 49:1 491:1 532:1 544:1 827:1 885:1 1179:1 1180:1 1183:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (DEPDC1)))(VP (VBD (required))(NP (NN (cell))(NN (cycle))(NN (progression))(NN (motility))(JJ (nasopharyngeal))(NN (carcinoma))))) |ET|  |BS| 16:C23.550.291.656 353:G04.299.134  |ES| 19:1 48:1 94:1 304:1 601:1 1174:1 1176:1 1177:1 1178:1  |EV| 
-1.5497332946183632884640246629715  |BT| (NP (NP (NN (Antitumor))(NN (function))(NN (microRNA-122))(JJ (hepatocellular))(NN (carcinoma)))) |ET|  |BS| 104:C04.557.470.200.025.255 184:D13.150.650.319  |ES| 19:1 33:1 303:1 304:1 1856:1 1857:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NNS (Tumors)))(VP (VBD (graded))(NP (NP (NN (histology))(JJ (immunostained))(NN (p53)))(, (,))(NP (JJ (adenomatous))(NN (polyposis))(NN (coli)))(, (,))(NP (NN (beta-catenin)))(, (,))(NP (NP (NP (NN (cyclooxygenase-2))(-LRB- (-LRB-))(NN (Cox-2))(-RRB- (-RRB-))(JJ (inducible))(JJ (nitric))(NN (oxide))(NN (synthase)))(PRN (-LRB- (-LRB-))(NP (NN (iNOS)))(-RRB- (-RRB-))))(VBN (sequenced))(NN (p53))(NN (mutation)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 3:C04.557.470.035.215.100 8:C04 18:G05.365.590 21:G05.360.340.024.340.375.249.050 22:D08.811.682.664.500.772.500 23:D12.776.091.249 24:D08.811.600.720.750 25:G02.111.570.080 26:G02.111.570.080 27:G02.111.570.080 28:H01.158.100.656  |ES| 2:1 10:1 12:1 14:1 19:1 34:1 53:1 54:1 55:1 56:1 57:1 58:1 59:1 60:1 61:1 62:1 63:1 64:1 65:1 66:1 67:1 68:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (JJ (Ectopic))(NN (expression))(NN (miR-139-5p))(NN (colon))(NN (cancer))(NN (cell))(NN (line)))(VP (ADVP (RB (significantly)))(NP (VBD (suppressed))(NP (NP (NN (cell))(NN (growth))(VBN (evidenced))(NN (cell))(NN (viability))(NN (assay)))(PRN (-LRB- (-LRB-))(S (NP (NN (P)))(VP (JJR (<))(NP (CD (0.001)))))(-RRB- (-RRB-))))(NP (NP (NP (NN (colony))(NN (formation))(NN (assay)))(PRN (-LRB- (-LRB-))(NP (NP (NN (P)))(ADJP (JJR (<))(NP (CD (0.01)))))(-RRB- (-RRB-))))(NP (NP (NN (xenograft))(NN (tumor))(NN (growth))(JJ (nude))(NN (mouse)))(PRN (-LRB- (-LRB-))(NP (NP (NN (P)))(ADJP (JJR (<))(NP (CD (0.01)))))(-RRB- (-RRB-)))))))) |ET|  |BS| 8:C04 20:G03.495 45:G07.700.320.249 88:B01.050.150.900.649.865.635.505.500.550.500 92:E04.936.764 93:A01.941.875 94:A11.251.210 106:E05.091 107:G05.355.315.202 108:G04.299.316 109:I01.696.116  |ES| 7:1 10:1 14:1 18:1 19:1 43:1 52:1 94:1 102:1 113:1 115:1 124:1 264:1 265:1 266:1 305:1 306:1 307:1 308:1 309:1 310:1 311:1 312:1 313:1 314:1 315:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (PP (IN (In))(NP (JJ (current))(NN (report))))(, (,))(VBN (used))(S (NP (NN (DLD-1))(JJ (colorectal))(NN (cancer))(NN (cell)))(ADVP (RB (stably)))(NP (VBN (transfected))(NP (NN (POX))(NN (gene))(NN (control))(JJ (tetracycline-inducible))(NN (promoter))))(VP (VBD (found))(SBAR (S (NP (CD (three))(NN (pathway))(NN (cross))(NN (talk)))(VP (VBD (downregulated))(NP (NP (NN (POX)))(: (:))(NP (NP (NP (NP (NN (cyclooxygenase-2)))(PRN (-LRB- (-LRB-))(NP (NN (COX-2)))(-RRB- (-RRB-))))(NN (pathway)))(, (,))(NP (NP (NP (JJ (epidermal))(NN (growth))(NN (factor))(NN (receptor)))(PRN (-LRB- (-LRB-))(NP (NN (EGFR)))(-RRB- (-RRB-))))(NN (pathway))(NN (Wnt/beta-catenin))(NN (pathway))))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 6:G05.360.340.024.340 23:D12.776.091.249 24:D08.811.600.720.750 41:A11 64:D08.811.913.696.620.682.725.400.009.300 146:D02.455.426.559.847.562.900.875 147:G02.149.115.800.925 148:G12.425.143.281  |ES| 2:1 9:1 10:1 14:1 17:1 18:1 19:1 37:1 61:1 76:1 83:1 94:1 102:1 104:1 175:1 184:1 185:1 186:1 187:1 244:1 289:1 302:1 383:1 417:1 426:1 476:1 477:1 478:1 479:1 480:1 481:1 482:1 483:1 484:1  |EV| 
-2.3036643834726504564969218336046  |BT| (S (NP (JJ (Additional))(NN (qRT-PCR))(NN (analysis)))(VP (VBD (revealed))(S (NP (JJ (gradual))(NN (elevation))(VBG (circulating))(NNS (miRNAs)))(-LRB- (-LRB-))(NP (FRAG (NP (FW (i.e.))(, (,))(NN (let-7a))(, (,))(NN (let-7f))(, (,))(NN (miR-34a))(, (,))(NN (miR-98))(, (,))(NN (miR-331))(, (,))(NN (miR-338))(NN (miR-652))(-RRB- (-RRB-))(NN (progress))(NN (hepatocarcinogenesis)))))))) |ET|  |BS| 184:D13.150.650.319 448:E05.393.620.500  |ES| 2:1 10:1 14:1 19:1 275:1 661:1 876:1 888:1 900:1 1110:1 1623:1 1821:1 1822:1 1823:1 1824:1 1825:1 1826:1 1827:1 1828:1 1829:1 1830:1 1831:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (Silencing))(NN (MLH1)))(VP (ADVP (RB (frequently)))(VBN (seen))(S (NP (JJ (sporadic))(JJ (colorectal))(NN (cancer)))))) |ET|  |BS| 4:C04.588.274.476.411.307 213:F02.830.816.964  |ES| 17:1 18:1 19:1 698:1 722:1 723:1 724:1 725:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (Detection)))(VP (VBN (methylated))(S (NP (NN (PAX5)))(VP (VBD (utilized))(NP (JJ (independent))(JJ (prognostic))(NN (factor))(NN (GC))))))) |ET|  |BS| 36:G02.111.087.029.538 243:D12.776.260.645.500  |ES| 19:1 185:1 554:1 846:1 883:1 884:1 1179:1 1180:1 1182:1  |EV| 
-0.024088451582656489335931837558746  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (NP (DT (The))(CD (two))(NN (library)))(ADVP (RB (differentially)))(VP (VBD (expressed))(SBAR (S (NP (NN (gene)))(VP (MD (may))(VP (VB (provide))(NP (NN (basis))(JJ (new))(NN (insight))(NN (clue))(NN (finding))(JJ (novel))(NN (lung))(JJ (cancer-related))(NN (gene)))))))))(: (;))(S (NP (JJ (several))(NN (gene)))(ADVP (RB (newly)))(VP (VBD (found))(NP (NP (NN (lung))(NN (cancer))(NN (ERGIC3)))(VP (VBG (seeming))(NP (JJ (novel))(NN (lung))(JJ (cancer-related))(NN (gene)))))))) |ET|  |BS| 9:G05.360.340.024.340.375.500 182:A04.411 259:D12.776.395.240.150.500 275:C23.888 343:G05.360.325 344:M01.438  |ES| 6:1 9:1 18:1 19:1 37:1 104:1 217:1 239:1 262:1 328:1 491:1 691:1 711:1 712:1 891:1 927:1 933:1 1138:1 1139:1 1140:1 1141:1 1142:1 1143:1 1144:1 1145:1 1146:1  |EV| 
4.6457201581691007774566060106736  |BT| (FRAG (NP (NNS (Results)))(VBP (show))(NP (NN (KLF9))(JJ (haploinsufficient))(NN (suppressor))(NN (colon))(NN (tumorigenesis))(NN (Apc)))(-LRB- (-LRB-))(NP (NP (NP (NP (NN (Min)))(: (/))(CC (+))(-RRB- (-RRB-))(NN (mouse))(NN (part)))(, (,))(NP (NP (NN (repression))(NN (ISG15))(NN (latter))(POS ('s)))(JJ (antiapoptotic))(NN (function)))))) |ET|  |BS| 3:C04.557.470.035.215.100 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 32:C04.697.098.500 33:C04.697.098 38:Z01.058.290.120.180 40:Z01.542.248.700 46:A03.556.124.526.356 207:G05.365.590.029.530.587 208:F01.393.821  |ES| 2:1 10:1 14:1 19:1 33:1 52:1 78:1 113:1 280:1 429:1 451:1 461:1 700:1 702:1 703:1 704:1 705:1 706:1 707:1 708:1 709:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (ADVP (RB (Moreover)))(, (,))(VP (VBD (identified))(SBAR (S (NP (NN (Usp28))(NN (c-MYC))(NN (target))(NN (gene)))(ADVP (RB (highly)))(VBD (expressed))(NP (JJ (murine))(JJ (human))(JJ (intestinal))(NN (cancer)))(, (,))(VP (VBZ (indicates))(SBAR (S (NP (NN (USP28))(NN (c-MYC))(NN (form))(JJ (positive))(NN (feedback))(NN (loop)))(VP (VBZ (maintains))(NP (JJ (high))(NN (c-MYC))(NN (protein))(NN (level))(NN (tumor))))))))))) |ET|  |BS| 8:C04 11:B01.050.150.900.649.865.635.505.500 55:B01.050.150.900.649.801.400.112.400.400 83:L01.143.283.425 101:C04.588.274.476.411 185:G05.360.340.024.340.375.500.791.420 186:G05.360.340.024.340.375.500.791.420 187:D08.622.705 188:N02.628 189:V02.460  |ES| 2:1 4:1 6:1 7:1 9:1 18:1 19:1 36:1 109:1 160:1 178:1 233:1 247:1 248:1 249:1 622:1 623:1 624:1 625:1 626:1 627:1 628:1 629:1 630:1 631:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (S (NP (NN (CRC))(NN (patient)))(VP (VBD (decreased))(NP (NN (level))(NN (miR-195-5p))(NN (tumor))(NN (tissue))))(S (ADVP (RB (significantly)))(VP (VBD (shortened))(SBAR (S (NP (NN (survival)))(VP (VBD (revealed))(NP (NP (NP (NN (TCGA))(NN (colon))(NN (adenocarcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (COAD)))(-RRB- (-RRB-))))(NN (dataset))(NN (CRC))(NN (cohort)))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 8:C04 46:A03.556.124.526.356 50:M01.643 84:C04.557.470.200.025 96:I03.784 97:V02.302 98:A10  |ES| 7:1 10:1 14:1 19:1 113:1 120:1 121:1 124:1 202:1 245:1 249:1 255:1 271:1 272:1 273:1 274:1 275:1 276:1 277:1 278:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (ADVP (RB (Moreover)))(, (,))(NP (NN (CDX2))(NN (expression)))(ADVP (RB (progressively)))(VP (VBD (reduced))(NP (JJ (gastric))(NN (dysplasia))(NN (cancer))))) |ET|  |BS| 70:A03.556.875.875  |ES| 2:1 18:1 19:1 86:1 114:1 115:1 201:1 203:1 452:1 622:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NNS (RESULTS))(: (:)))(VP (ADVP (RB (Herein)))(VB (provide))(NP (JJ (new))(NP (NN (evidence))(JJ (transcriptional))(NN (regulation)))(NN (Notch))(NN (PEA3))(NN (breast))(NN (cancer))))) |ET|  |BS| 142:I01.880.604 209:G02.111.087.847  |ES| 18:1 19:1 23:1 38:1 104:1 256:1 428:1 438:1 559:1 710:1 711:1 712:1 713:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (DT (The))(JJ (unbalanced))(NN (translocation)))(, (,))(NP (NN (der))(-LRB- (-LRB-))(CD (17))(-RRB- (-RRB-))(-LRB- (-LRB-))(NN (X))(: (;))(CD (17))(-RRB- (-RRB-))(-LRB- (-LRB-))(NN (p11))(NN (.2))(: (;))(CD (q25)))(-RRB- (-RRB-))(, (,))(NP (NP (JJ (characteristic))(JJ (alveolar))(JJ (soft))(NN (part))(NN (sarcoma)))(PRN (-LRB- (-LRB-))(NP (NN (ASPS)))(-RRB- (-RRB-))))) |ET|  |BS| 439:C04.557.450.590.775 463:C23.550.210.870  |ES| 2:1 10:1 14:1 19:1 217:1 336:1 451:1 691:1 923:1 929:1 930:1 931:1 932:1 1117:1 1287:1 1524:1 1617:1 1618:1 1619:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NP (ADVP (RB (Surprisingly)))(, (,))(VBN (given))(VBN (proposed))(NN (role))(NN (loss))(NN (function))(NN (mutation))(NN (p53))(NN (gene))(NN (development)))(NP (JJ (human))(JJ (colorectal))(NN (cancer)))(, (,)))(VP (VBD (found))(NP (NP (NN (evidence)))(PP (CC (either))(NP (NP (NN (increase))(NN (rate))(NN (adenoma))(NN (formation))(NN (APC)))(CC (+))(: (/))(: (-))(, (,))(NP (NN (p53))(: (-)))(: (/))(FRAG (: (-))(NP (NP (NN (animal)))(, (,))(NP (NP (VBD (increased))(NN (rate))(NN (progression))(NN (malignancy)))(VP (VBN (compared))(NP (NP (NN (APC)))(NP (CC (+))(: (/))(: (-))(NN (p53))(CC (+))(FRAG (: (/))(CC (+))(NP (NN (mouse))))))))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 11:B01.050.150.900.649.865.635.505.500 12:Z01.542.049 13:D01.339.387 14:F01.525 15:F01.829.316.616 16:C23.550.291.656 17:C04.557.470.035 18:G05.365.590 19:B01.050 20:G03.495  |ES| 2:1 9:1 11:1 12:1 17:1 18:1 19:1 28:1 29:1 30:1 31:1 32:1 33:1 34:1 35:1 36:1 37:1 38:1 39:1 40:1 41:1 42:1 43:1 44:1 45:1 46:1 47:1 48:1 49:1 50:1 51:1 52:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (DT (The))(NN (analysis))(JJ (clinical))(JJ (characteristic)))(VP (VBD (showed))(SBAR (S (NP (NN (miR-141)))(ADVP (RB (significantly)))(VP (VBD (downregulated))(NP (NN (tissue))(NN (cell))(NN (line))(JJ (pancreatic))(NN (cancer)))))))) |ET|  |BS| 94:A11.251.210 98:A10  |ES| 18:1 19:1 84:1 94:1 124:1 132:1 264:1 272:1 336:1 426:1 463:1 467:1 661:1 691:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NNP (LOH))(NNP (FHIT))(NN (locus)))(ADVP (RB (frequently)))(VP (VBN (found))(PP (IN (among))(NP (NN (lesion))(NNS (metaplasias))(JJ (bronchiolar))(NN (epithelium))(NN (patient))(NN (IPF))))(PRN (-LRB- (-LSB-))(NP (NP (CD (62))(PRN (-LRB- (-LRB-))(NP (CD (52))(NN (%)))(-RRB- (-RRB-))))(NP (CD (119))(JJ (informative))(NN (lesion))))(-RRB- (-RSB-))))) |ET|  |BS| 48:C23.550.589 50:M01.643 62:A10.272 276:C08.381.483.487.500 290:G05.365.590.029.530 337:C08.381.765 365:A04.411.125.500  |ES| 10:1 14:1 19:1 37:1 120:1 173:1 369:1 377:1 698:1 946:1 1004:1 1122:1 1131:1 1222:1 1223:1 1372:1 1373:1 1374:1 1375:1 1376:1 1377:1 1378:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (JJ (Epigenetic))(NN (dysregulation))(JJ (leukaemic))(NN (HOX))(NN (code))(JJ (MLL-rearranged))(NN (leukaemia))(NN (mouse))(NN (model)))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 360:N04.452.758.708.200.400.500 361:C04.557.337  |ES| 19:1 52:1 72:1 1201:1 1202:1 1203:1 1204:1 1205:1 1206:1 1207:1  |EV| 
4.6457201581691007774566060106736  |BT| (FRAG (PP (IN (As))(NP (NP (JJ (incomplete))(JJ (intestinal))(NN (metaplasia)))(VP (VBN (associated))(NP (NP (JJR (higher))(NN (risk))(JJ (gastric))(NN (cancer)))(, (,))(NP (JJR (lower))(NN (CDX2))(NN (expression)))(VP (VBD (compared))(NP (NP (JJ (complete))(JJ (intestinal))(NN (metaplasia))(JJ (normal))(NN (colon))(NN (epithelium)))(VP (VBN (resolved))(NP (NP (JJ (current))(NN (contradiction))(JJ (tumor-suppressive))(NN (role)))(NN (CDX2))(NN (colon))(JJ (high))(NN (prevalence))(NN (CDX2))(JJ (intestinal))(NN (metaplasia))))))))))) |ET|  |BS| 8:C04 15:F01.829.316.616 46:A03.556.124.526.356 47:A03.556.124 48:C23.550.589 60:E05.318.308.985.525.750 61:E05.318.740.600.800 62:A10.272  |ES| 2:1 18:1 19:1 31:1 50:1 86:1 108:1 109:1 110:1 113:1 114:1 115:1 117:1 118:1 168:1 169:1 170:1 171:1 172:1 173:1 174:1 175:1 176:1 177:1 178:1 179:1  |EV| 
-1.2030024076385643638786859810352  |BT| (S (NP (PRP (We)))(VP (VBD (explored))(NP (NP (JJ (potential))(NN (TFPI2))(NN (biomarker))(JJ (early))(NN (detection))(NN (CRC)))(VP (VBG (using))(NP (NP (NN (stool))(JJ (DNA-based))(NN (assay))(NN (patient)))(JJ (nonmetastatic))(NN (CRC))(JJ (average-risk))(NN (noncancer))(NN (control))(NN (candidate))(NN (screening))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 50:M01.643 61:E05.318.740.600.800 106:E05.091 158:D23.101 198:D13.444.308 333:D01.045 355:A12.459 375:Z01.639.100 494:E01.390  |ES| 19:1 120:1 245:1 289:1 310:1 350:1 499:1 827:1 843:1 885:1 1023:1 1128:1 1184:1 1185:1 1188:1 1243:1 1744:1 1745:1 1746:1 1747:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (Sil))(NN (gene))(NN (expression))(NN (lung))(NN (cancer)))(VP (VBD (correlated))(NP (NN (expression))(JJ (several))(NN (kinetochore))(NN (check-point))(NN (gene))(JJ (histopathologic))(JJ (mitotic))(NN (index))))) |ET|  |BS| 155:G05.355.310 211:A11.284.430.106.279.345.190.160.165.500 212:E01.370.225.500.385.500  |ES| 9:1 18:1 19:1 115:1 262:1 328:1 446:1 716:1 717:1 718:1 719:1 720:1 721:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (JJ (Mammary))(NN (analogue))(JJ (secretory))(NN (carcinoma))(JJ (salivary))(NN (gland))(JJ (high-grade))(NN (transformation)))(: (:))(NP (NP (NN (report))(ADJP (CD (3))(NN (case)))(NN (ETV6-NTRK3))(NN (gene))(NN (fusion))(NN (analysis))(NN (TP53)))(, (,))(NP (NN (beta-catenin)))(, (,))(NP (NN (EGFR)))(, (,))(NP (NN (CCND1))(NN (gene))))) |ET|  |BS| 23:D12.776.091.249 359:G05.355.760.385 402:G05.360.340.024.340.375.500.791.148 403:C04.557.470.200.588 404:A03.556.500.760 405:V03.100 406:V03.100  |ES| 2:1 9:1 19:1 60:1 104:1 187:1 304:1 417:1 643:1 661:1 862:1 934:1 936:1 1018:1 1025:1 1379:1 1380:1 1381:1 1382:1 1383:1 1384:1 1385:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (DT (The))(NN (adhesion))(NN (molecule))(NN (L1CAM)))(VP (VBZ (mediates))(S (NP (NN (chemoresistance))(NN (migration))(NN (tumor))(NN (cell))(JJ (elevated))(NN (CRC))(NN (tissue)))(NP (VBN (associated))(JJ (metastatic))(NN (spread))(JJ (poor))(NN (prognosis))(NN (patient)))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 50:M01.643 98:A10 113:C04.697.650 159:I01.880.735.634 163:E01.789 221:D12.776.395.550.200.250.520.578 222:D12.776.395.550.200  |ES| 7:1 19:1 94:1 120:1 169:1 180:1 182:1 245:1 272:1 337:1 514:1 544:1 545:1 691:1 753:1 754:1 755:1 756:1 757:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (Penta-1,2,3,4,6-O-galloyl-beta-D-glucose)))(VP (VP (VBZ (induces))(SBAR (S (NP (NN (p53)))(VP (VBZ (inhibits))(NP (NN (STAT3))(NN (prostate))(NN (cancer))(NN (cell))(NN (vitro)))))))(VP (VBZ (suppresses))(NP (NN (prostate))(NN (xenograft))(NN (tumor))(NN (growth)))(FW (vivo))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 41:A11 45:G07.700.320.249 82:D12.644.360.024.342.300 91:D09.546.359.448 92:E04.936.764 93:A01.941.875 122:C14.280.383 202:C04.588.945.440.770  |ES| 7:1 12:1 18:1 19:1 77:1 94:1 102:1 214:1 216:1 251:1 265:1 378:1 615:1 685:1 686:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (ADVP (RB (Furthermore)))(, (,))(NP (NN (Cdx2)))(VP (VBD (decreased))(S (VP (VBG (knocking))(NP (NN (HNF4alpha))(JJ (human))(NN (colon))(NN (cancer))(NN (cell)))(S (VP (VBG (using))(NP (NN (siRNA))(NN (colon))(NN (mouse))))))))(S (ADVP (RB (conditionally)))(VP (VBD (knocked))(NP (NN (Hnf4alpha))(NN (gene))(JJ (adult))(NN (intestine)))(PRN (-LRB- (-LRB-))(NP (NP (NP (NN (Hnf4alpha)))(PRN (-LRB- (-LRB-))(NP (NN (f/f)))(-RRB- (-RRB-))))(: (;))(NP (NNP (VilCre))(-LRB- (-LRB-))(NN (ERT2))(-RRB- (-RRB-))(NN (mouse))))(-RRB- (-RRB-)))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 41:A11 46:A03.556.124.526.356 47:A03.556.124 55:B01.050.150.900.649.801.400.112.400.400 116:D08.811.913.696.620.682.700.567.249.750 117:D13.150.650.700 118:D01.248.497.158.380 119:M01.060.116  |ES| 2:1 9:1 10:1 14:1 18:1 19:1 36:1 52:1 94:1 113:1 123:1 202:1 213:1 217:1 334:1 349:1 350:1 351:1 352:1 353:1 354:1 355:1 356:1 357:1 358:1 359:1  |EV| 
-4.049254640508479496929794549942  |BT| (S (NP (NN (CD133)))(VP (VBN (considered))(S (NP (NP (JJ (stem-like))(NN (cell))(NN (marker))(NN (cancer)))(PP (VBG (including))(NP (NP (JJ (gastric))(NN (cancer)))(, (,))(NP (NP (NN (Notch1))(NN (signaling)))(VP (VBN (known))(NP (NN (play))(JJ (important))(NN (role))(NN (maintenance))(NN (differentiation))(JJ (stem-like))(NN (cell))))))))))) |ET|  |BS| 12:Z01.542.049 15:F01.829.316.616 30:Z01.058.290.190.800 31:D08.811.520.224.800 69:G02.111.087.800 74:G04.299.151 79:I03.450.642.693 158:D23.101 188:N02.628 308:A11.872 309:A18.024.937  |ES| 2:1 18:1 19:1 31:1 86:1 94:1 195:1 215:1 238:1 534:1 556:1 561:1 651:1 652:1 902:1 1061:1 1062:1 1063:1  |EV| 
-4.6457201581691007774566060106736  |BT| (SINV (PP (IN (Of))(NP (JJ (small-cell))(JJ (heterogeneous))(JJ (basophilic))(NN (lesion))))(, (,))(CD (86))(VP (NN (%))(VP (NN (focus))(SBAR (S (-LRB- (-LRB-))(S (S (NP (NP (QP (CD (31/36))(-RRB- (-RRB-))(CD (85))(NN (%)))(NN (adenoma)))(PRN (-LRB- (-LRB-))(NP (CD (35/41)))(-RRB- (-RRB-))))(VP (VBD (exhibited))(NP (NP (VBN (increased))(NN (bcl-2))(NN (protein))(NN (level)))(PP (VBN (compared))(S (VP (VBG (surrounding))(NP (JJ (normal))(NNS (hepatocytes)))))))))(, (,))(IN (whereas))(S (NP (NP (NP (ADJP (CD (12.5))(NN (%)))(NN (focus)))(PRN (-LRB- (-LRB-))(NP (CD (4/36)))(-RRB- (-RRB-))))(ADJP (CD (12))(NN (%)))(NN (adenoma))(PRN (-LRB- (-LRB-))(NP (CD (5/41)))(-RRB- (-RRB-))))(VP (VBD (exhibited))(NP (NP (NP (VBN (increased))(NN (bcl-X)))(PRN (-LRB- (-LRB-))(NP (NN (L)))(-RRB- (-RRB-))))(NN (level))))))))))) |ET|  |BS| 7:D12.776 17:C04.557.470.035 41:A11 54:G05.360.340.024.340.375.500.791.150 175:J01.897.280.500.269 262:A11.436.348 418:D12.644.360.075.718.937 420:A11.118.637.415.120 421:G05.365.331 422:N01  |ES| 2:1 4:1 10:1 14:1 19:1 42:1 47:1 50:1 118:1 151:1 249:1 369:1 372:1 609:1 894:1 1120:1 1131:1 1429:1 1431:1 1435:1 1436:1 1437:1 1442:1 1443:1 1444:1 1445:1 1446:1 1447:1 1448:1 1449:1 1450:1 1451:1  |EV| 
4.6457201581691007774566060106736  |BT| (FRAG (PP (IN (In))(NP (NN (study))))(, (,))(NP (VBN (explored))(NN (role))(NN (miR-141))(JJ (pancreatic))(NN (cancer)))) |ET|  |BS| 15:F01.829.316.616  |ES| 2:1 18:1 19:1 31:1 131:1 244:1 463:1 467:1 499:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NP (DT (The))(JJ (adenomatous))(NN (polyposis))(NN (coli))(-LRB- (-LRB-))(NN (APC))(-RRB- (-RRB-))(NN (gene))(NN (product)))(NP (VBN (mutated))(JJ (vast))(NN (majority))(JJ (human))(JJ (colorectal))(NN (cancer))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 219:G05.360.340.024.340.375.249.320 220:D05.500.117.249  |ES| 9:1 10:1 11:1 14:1 17:1 18:1 19:1 36:1 57:1 58:1 59:1 198:1 229:1 675:1 691:1 752:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (JJ (Aberrant))(NN (methylation))(NN (SPARC))(NN (gene))(NN (promoter))(JJ (clinical))(NN (implication))(JJ (gastric))(NN (cancer)))) |ET|  |BS| 35:G02.111.570.080.689.675 36:G02.111.087.029.538 37:D12.776.157.125.715  |ES| 9:1 18:1 19:1 80:1 81:1 82:1 83:1 84:1 85:1 86:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NP (VBN (Increased))(NN (loss))(NN (chromosome))(NN (9p21))(NN (p16))(NN (inactivation)))(NP (JJ (primary))(JJ (non-small))(NN (cell))(NN (lung))(NN (cancer))(NN (smoker))))) |ET|  |BS| 110:C04.588.894.797.520.109.220.249 203:G05.360.340.024.340.375.249.375 289:A11.284.187  |ES| 18:1 19:1 32:1 94:1 328:1 344:1 694:1 1005:1 1212:1 1312:1 1313:1 1314:1 1315:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NP (NP (NN (Overexpression))(NN (progastrin)))(, (,))(NP (JJ (nonamidated))(ADJP (RB (incompletely))(VBN (processed)))(NN (product))(NN (gastrin))(NN (gene)))(, (,)))(VP (VBN (shown))(VP (VBP (induce))(NP (JJ (colonic))(NN (hyperproliferation))))))(VP (VBP (promote))(NP (NP (JJ (colorectal))(NN (cancer))(NN (mouse)))(, (,))(NP (NP (NN (mechanism))(NN (pathogenesis)))(VP (VBN (defined))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 7:D12.776 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 46:A03.556.124.526.356 199:D06.472.317.413 200:D06.472.317.413  |ES| 2:1 9:1 17:1 18:1 19:1 52:1 162:1 237:1 243:1 501:1 668:1 671:1 672:1 673:1 674:1 675:1 676:1 677:1 678:1 679:1 680:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (Notch1)))(ADVP (RB (directly)))(VP (VBD (induced))(NP (NN (CD133))(NN (expression))(JJ (human))(JJ (diffuse))(NN (type))(JJ (gastric))(NN (cancer))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400  |ES| 18:1 19:1 36:1 86:1 115:1 412:1 543:1 621:1 651:1 652:1 653:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (ADVP (RB (Collectively)))(, (,))(NP (NN (miR-122))(NN (depletion)))(VP (VBZ (facilitates))(NP (NP (NN (cystogenesis))(NN (hepatocarcinogenesis))(NN (mouse))(NN (DEN))(NN (challenge)))(VP (VBG (up-regulating))(NP (NP (JJ (several))(NN (gene)))(VP (VBN (involved))(NP (NP (NN (proliferation)))(, (,))(NP (NN (growth))(NN (factor))(NN (signaling)))(, (,))(NP (NN (neovascularization)))(, (,))(NP (NN (metastasis)))))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 69:G02.111.087.800 113:C04.697.650 150:Z01.542.248.960 344:M01.438 530:C23.550.589.500  |ES| 2:1 9:1 19:1 52:1 102:1 185:1 195:1 262:1 299:1 774:1 806:1 900:1 1371:1 1613:1 1789:1 1872:1 1873:1 1874:1 1875:1 1876:1 1877:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NP (NP (JJ (Altered))(NN (expression))(JJ (human))(NN (enhancer))(NN (filamentation))(CD (1)))(PRN (-LRB- (-LRB-))(NP (NP (NN (HEF1)))(: (;))(NP (ADJP (RB (also))(VBN (known)))(NN (NEDD9))(NN (Cas-L))))(-RRB- (-RRB-))))(NP (VBN (implicated))(NN (progression))(NN (melanoma))(, (,))(NN (breast))(, (,))(NN (CRC))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 10:A01.236 15:F01.829.316.616 16:C23.550.291.656 32:C04.697.098.500 33:C04.697.098 55:B01.050.150.900.649.801.400.112.400.400 142:I01.880.604 239:F02.463.188.357 282:C04.557.465.625.650.510  |ES| 2:1 5:1 10:1 14:1 19:1 23:1 31:1 36:1 48:1 78:1 98:1 115:1 217:1 245:1 433:1 438:1 556:1 889:1 971:1 972:1 973:1 974:1 975:1 976:1 977:1 978:1 979:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NP (NN (miRNA-141)))(, (,))(VP (VBD (downregulated))(NP (JJ (pancreatic))(NN (cancer))))(, (,)))(VP (VBZ (inhibits))(NP (NN (cell))(NN (proliferation))(NN (invasion)))(S (VP (ADVP (RB (directly)))(VBG (targeting))(NP (NN (MAP4K4))))))) |ET|  |BS| 122:C14.280.383 183:G04.299.233.750 184:D13.150.650.319  |ES| 2:1 18:1 19:1 94:1 299:1 426:1 465:1 467:1 615:1 616:1 619:1 620:1 621:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (Evaluation))(NN (RB))(NN (status)))(VP (MD (may))(NP (JJ (useful))(JJ (prognostic))(NN (factor))(JJ (human))(NN (HCC))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 104:C04.557.470.200.025.255 225:E05.337  |ES| 19:1 36:1 185:1 416:1 441:1 491:1 884:1 1036:1 1208:1 1209:1  |EV| 
-4.6457201581691007774566060106736  |BT| (FRAG (SBAR (IN (Although))(S (NP (NN (CTCF)))(VP (VBD (described))(NP (NP (NP (ADJP (RB (significantly))(VBN (mutated)))(NN (gene))(JJ (endometrial))(NN (cancer))(NN (TCGA)))(, (,))(NP (NN (A))(-LRB- (-LRB-))(CD (7))(-RRB- (-RRB-))(NN (track))))(SBAR (S (NP (JJ (variant))(VBG (leading))(NN (T204))(NNS (frameshifts)))(VP (VBD (reported)))))))))) |ET|  |BS| 6:G05.360.340.024.340 86:D01.268.556.435 286:C04.588.945.418.948.585 287:G05.365.590.265  |ES| 2:1 9:1 10:1 14:1 18:1 19:1 69:1 107:1 124:1 229:1 276:1 634:1 639:1 986:1 987:1 988:1 989:1 990:1 991:1 992:1 993:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NP (DT (The))(NN (lung))(NN (adenocarcinoma))(NN (cell))(NN (bearing))(JJ (K-ras))(NN (gene))(NN (mutation)))(PRN (-LRB- (-LRB-))(NP (NN (A549))(NN (H820)))(-RRB- (-RRB-))))(VP (VBD (showed))(NP (ADJP (RB (consistently))(JJR (higher)))(NN (level))(NN (cell))(NN (motility)))(S (PP (IN (without))(NP (NP (NN (mutation)))(PRN (-LRB- (-LRB-))(NP (NN (TKB6))(NN (TKB14)))(-RRB- (-RRB-)))))(, (,))(NP (NN (motility))(NN (A549))(NN (H820))(NN (cell)))(ADVP (RB (significantly)))(VP (VBD (inhibited))(NP (NN (dnAkt))(NN (transfection))))))) |ET|  |BS| 18:G05.365.590 41:A11 122:C14.280.383 217:E05.393.350.810 455:B01.050.150.900.649.147.890  |ES| 2:1 9:1 10:1 14:1 19:1 34:1 94:1 124:1 132:1 170:1 249:1 255:1 328:1 364:1 365:1 691:1 746:1 1121:1 1177:1 1195:1 1584:1 1585:1 1586:1 1587:1 1588:1 1589:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (PRP$ (Our))(NP (NP (JJ (recent))(JJ (global))(NN (analysis))(NN (CpG))(NN (island))(NN (hypermethylation))(NN (gene))(NN (expression))(JJ (colorectal))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (CRC)))(-RRB- (-RRB-))))(NN (cell))(NN (line)))(VP (VBD (revealed))(S (NP (NN (SOX17))(NN (gene))(NN (silencing)))(NP (VBN (associated))(NN (DNA))(NN (hypermethylation))(NN (CpG))(NN (island))(NN (promoter))(NN (region)))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 42:G05.355.315.203.374 94:A11.251.210 155:G05.355.310 195:G02.111.570.080.380.160 196:G02.111.570.080.689.675 197:A01.456.505.420 198:D13.444.308  |ES| 9:1 10:1 14:1 17:1 18:1 19:1 83:1 94:1 100:1 115:1 169:1 245:1 264:1 275:1 658:1 659:1 660:1 661:1 662:1 663:1 664:1 665:1 666:1 667:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NN (INTRODUCTION)))(: (:))(NP (NP (NP (NP (JJ (Triple))(JJ (negative))(NN (breast))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (TNBC)))(-RRB- (-RRB-))))(NP (JJ (aggressive))(ADJP (RB (currently))(JJ (specific)))(JJ (therapeutic))(NN (target))))(, (,))(NP (NP (NN (hormone))(NN (receptor))(JJ (human))(JJ (epidermal))(NN (growth))(NN (factor))(NN (receptor))(NN (type))(CD (2)))(PRN (-LRB- (-LRB-))(NP (NN (HER2)))(-RRB- (-RRB-)))))(: (;))(ADVP (RB (therefore)))(, (,))(NP (NN (prognosis))(JJ (poor)))) |ET|  |BS| 52:E02 63:G05.360.340.024.340.375.500.791.295.305 65:D08.811.913.696.620.682.725.400.009.400 159:I01.880.735.634 160:C04.588.180.788 161:D06.472 162:F01.145.126.125 163:E01.789  |ES| 2:1 10:1 14:1 18:1 19:1 23:1 36:1 102:1 104:1 148:1 160:1 184:1 185:1 186:1 188:1 217:1 218:1 449:1 535:1 536:1 537:1 538:1 539:1 540:1 541:1 542:1 543:1 544:1 545:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NP (NN (CDX2)))(, (,))(NP (NN (master))(NN (regulator))(JJ (intestinal))(NN (phenotype)))(, (,)))(VP (VBN (shown))(NP (NN (play))(JJ (tumor-suppressive))(NN (role))(NN (colon))(NN (cancer))))) |ET|  |BS| 15:F01.829.316.616 30:Z01.058.290.190.800 31:D08.811.520.224.800 47:A03.556.124 51:C04.588.274.476.411.307.180 79:I03.450.642.693 80:G05.695  |ES| 2:1 18:1 19:1 31:1 109:1 113:1 114:1 177:1 234:1 235:1 236:1 237:1 238:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (PURPOSE))(: (:)))(NP (DT (The))(NN (MYC))(NN (oncogene)))(ADVP (RB (frequently)))(VP (VBN (overexpressed))(NP (NN (prostate))(NN (cancer))))) |ET| 18:1 19:1 24:1 25:1 77:1 104:1 472:1 687:1 691:1 698:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (PRP$ (Our))(S (VP (NN (finding))(VP (VB (identify))(NP (NN (EphA1))(JJ (potential))(JJ (prognostic))(NN (marker))(NN (CRC)))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 158:D23.101  |ES| 19:1 245:1 534:1 658:1 827:1 832:1 884:1 927:1 994:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (JJ (Irrespective))(NN (protein))(NN (overexpression)))(, (,))(S (NP (NN (HER-2)))(: (/))(NP (NP (NN (neu))(NN (gene))(NN (amplification))(JJ (rare))(NN (lung))(NN (cancer))(NN (study))(NN (prevalence))(JJ (clinicopathological))(NN (implication))(JJ (early))(NN (stage))(JJ (non-small))(NN (cell))(NN (lung))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (NCSLC)))(-RRB- (-RRB-))))(NP (NP (JJ (neuroendocrine))(NN (tumour)))(PRN (-LRB- (-LRB-))(NP (NN (NET)))(-RRB- (-RRB-))))(VP (NN (lung))(S (VP (VBG (lacking))))))) |ET|  |BS| 7:D12.776 63:G05.360.340.024.340.375.500.791.295.305 110:C04.588.894.797.520.109.220.249 237:C04.588.894.797.520 391:E05.318.760.500.875 392:G05.355.315.250 393:A06.688  |ES| 2:1 4:1 9:1 10:1 14:1 18:1 19:1 85:1 94:1 131:1 152:1 179:1 328:1 376:1 694:1 921:1 1011:1 1128:1 1129:1 1320:1 1321:1 1322:1 1323:1 1324:1 1325:1 1326:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (NP (NN (Reduction))(NN (ING1b))(NN (gene))(NN (expression)))(VP (VBN (associated))(VP (VBD (reduced))(NP (NN (p21))(NN (bax))(NN (gene))(NN (expression))(NNS (NSCLCs))))))) |ET|  |BS| 110:C04.588.894.797.520.109.220.249 155:G05.355.310 342:D12.644.360.075.718.400  |ES| 9:1 19:1 104:1 115:1 169:1 239:1 452:1 1133:1 1134:1 1135:1 1136:1 1137:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NP (NN (Germline))(JJ (somatic))(NN (mutation))(NN (BER))(NN (gene)))(, (,))(NP (NP (NN (MutY))(NN (Homolog)))(PRN (-LRB- (-LRB-))(NP (NN (MUTYH/MYH)))(-RRB- (-RRB-))))(NP (NP (JJ (DNA-directed))(NN (polymerase)))(PRN (-LRB- (-LRB-))(NP (NN (POLB)))(-RRB- (-RRB-))))(, (,)))(NP (VBN (associated))(VBN (increased))(NN (risk))(JJ (colorectal))(NN (cancer)))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 18:G05.365.590 61:E05.318.740.600.800 127:D08.811.913.696.445.308.300 128:E02.095.301 129:G02.111.087.219 130:A05.360.490  |ES| 2:1 9:1 10:1 14:1 17:1 18:1 19:1 34:1 47:1 169:1 171:1 387:1 388:1 389:1 390:1 391:1 392:1 393:1 394:1 395:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (JJ (Correlated))(NN (pattern)))(VP (VBN (observed))(NP (NP (NN (HNF4alpha))(NN (Cdx2))(JJ (several))(JJ (experimental))(NN (model))(JJ (human))(NN (colon))(NN (cancer))(NN (cell))(NN (line)))(: (:))(NP (NP (NN (xenograft))(JJ (nude))(NN (mouse)))(, (,))(NP (NN (wound))(NN (healing))(NN (glucose))(NN (starvation))))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 88:B01.050.150.900.649.865.635.505.500.550.500 89:G16.100.856.891 90:C18.654.521.750 91:D09.546.359.448 92:E04.936.764 93:A01.941.875 94:A11.251.210 95:E05.599  |ES| 2:1 18:1 19:1 36:1 52:1 72:1 94:1 104:1 113:1 123:1 213:1 259:1 260:1 261:1 262:1 263:1 264:1 265:1 266:1 267:1 268:1 269:1 270:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NP (NN (Mutation))(NN (Pla2g2a)))(, (,))(NP (JJ (secretory))(NN (phospholipase))(NN (A))(-LRB- (-LRB-))(CD (2))(-RRB- (-RRB-)))(NP (NN (gene)))(, (,)))(VP (VP (ADVP (RB (dramatically)))(VB (increase))(NP (NN (number))(JJ (intestinal))(NN (polyp)))(VP (VB (develop))(NP (NP (NP (JJ (multiple))(JJ (intestinal))(NN (neoplasia)))(PRN (-LRB- (-LRB-))(NP (NN (Min)))(-RRB- (-RRB-))))(NN (mouse)))))(, (,))(NP (JJ (murine))(ADJP (NN (model))(JJ (adenomatous))(NN (polyposis))(NN (coli))(JJ (human)))))) |ET|  |BS| 3:C04.557.470.035.215.100 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 21:G05.360.340.024.340.375.249.050 55:B01.050.150.900.649.801.400.112.400.400 102:C04.588.274.476.411 192:D08.811.277.352.100.680.750.937.750 193:C23.300.825.411  |ES| 2:1 9:1 10:1 14:1 19:1 36:1 40:1 52:1 57:1 58:1 59:1 69:1 72:1 109:1 148:1 627:1 640:1 641:1 642:1 643:1 644:1 645:1 646:1 647:1 648:1 649:1 650:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (DT (A))(NN (relationship))(JJ (renal))(NN (tumor))(NN (ASPS)))(ADVP (RB (initially)))(VP (VBD (suggested))(NP (JJ (cytogenetic))(NN (finding))(JJ (balanced))(-LRB- (-LRB-))(NN (X))(: (;))(CD (17))(-RRB- (-RRB-))(-LRB- (-LRB-))(NN (p11))(NN (.2))(: (;)))(NP (CD (q25)))(-RRB- (-RRB-))(SBAR (S (NP (NP (CD (two))(NN (case)))(, (,))(NP (NN (ASPL-TFE3))(NN (fusion))(NN (transcript))))(VP (VBD (confirmed))(NP (JJ (reverse))(NN (transcriptase-polymerase))(NN (chain))(NN (reaction)))))))) |ET|  |BS| 272:E05.393.620.500.725 273:H01.158.273.343.180 274:C04.588.945.947.535 275:C23.888  |ES| 2:1 7:1 10:1 14:1 19:1 69:1 217:1 223:1 768:1 922:1 923:1 924:1 925:1 926:1 927:1 928:1 929:1 930:1 931:1 932:1 933:1 934:1 935:1 936:1 937:1 938:1 939:1 940:1 941:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (DT (The))(JJ (apoptosis-inducing))(NN (effect))(NN (gastrin))(JJ (colorectal))(NN (cancer))(NN (cell)))(VP (VBZ (relates))(NP (NP (VBN (increased))(NP (NN (IEX-1)))(NN (expression)))(VP (VBG (mediating))(NP (NP (NN (NF-kappa))(NN (B)))(NN (inhibition))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 39:G04.299.139.160 41:A11 43:F01.145.544 199:D06.472.317.413 200:D06.472.317.413 210:D12.776.260.600  |ES| 17:1 18:1 19:1 47:1 75:1 94:1 103:1 115:1 676:1 691:1 758:1 759:1 760:1 761:1 762:1 763:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NNS (METHODS))(: (:)))(S (NP (NN (Notch))(NN (status)))(VP (VBD (analysed))(S (VP (VBG (studying))(S (NP (NN (expression))(NN (Notch))(NN (effector))(NN (Hes1))(NN (Notch))(NNS (ligands/receptors)))(NP (JJ (human))(JJ (colorectal))(NP (NP (NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (CRC)))(-RRB- (-RRB-))))(NN (mouse))(NN (model))(NN (Apc))(NN (mutation))))))))) |ET|  |BS| 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 55:B01.050.150.900.649.801.400.112.400.400 168:E05.581 169:D12.776.543.750.725 170:D27.720.470.480  |ES| 10:1 14:1 17:1 18:1 19:1 34:1 36:1 52:1 72:1 104:1 115:1 245:1 256:1 258:1 280:1 416:1 565:1 568:1 569:1 570:1 571:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NN (PURPOSE))(CC (AND))(JJ (EXPERIMENTAL))(NN (DESIGN)))(: (:))(NP (NP (DT (The))(JJ (molecular))(NN (mechanism))(NN (p14ARF))(NN (gene)))(ADJP (JJ (altered))(SBAR (S (NP (NP (JJ (non-small))(NN (cell))(NN (lung))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (NSCLC)))(-RRB- (-RRB-))))(VP (NN (complex))(ADJP (JJ (unclear))))))))) |ET|  |BS| 110:C04.588.894.797.520.109.220.249 203:G05.360.340.024.340.375.249.375 204:E05.581.500 205:E05.581.500  |ES| 9:1 10:1 14:1 18:1 19:1 94:1 104:1 161:1 162:1 328:1 329:1 443:1 687:1 688:1 689:1 690:1 691:1 692:1 693:1 694:1 695:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (Detection))(NN (TFPI2))(NN (methylation))(NN (stool))(NN (DNA)))(VP (MD (may))(VP (VB (act))(NP (JJ (useful))(NN (adjunct))(JJ (noninvasive))(NN (strategy))(NN (screening))(NNS (CRCs))(NN (future)))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 36:G02.111.087.029.538 81:E02.095.465.425.400.330.050.400 198:D13.444.308 354:I01.320 355:A12.459  |ES| 19:1 81:1 246:1 491:1 666:1 1036:1 1114:1 1179:1 1184:1 1185:1 1186:1 1187:1 1188:1 1189:1 1190:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (SBAR (IN (Although))(S (NP (NP (NN (therapy)))(VP (VBG (targeting))(NP (JJ (high))(NN (EphA1))(NN (expression)))))(VP (VBP (seem))(NP (JJ (plausible))(NN (CRC))))))(, (,))(S (NP (NN (loss))(NN (expression)))(VP (VBD (advanced))(NP (NN (disease)))))(VP (VBZ (suggests))(SBAR (S (NP (NP (NP (JJ (potential))(NN (risk)))(VBN (targeted))(NN (therapy)))(, (,))(VP (VBG (selecting))(NP (NN (loss))(NN (expression))))(, (,)))(VP (MD (might))(VP (VB (contribute))(NP (NN (disease))(NN (progression))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 16:C23.550.291.656 38:Z01.058.290.120.180 40:Z01.542.248.700 52:E02 61:E05.318.740.600.800 288:C23.550.288  |ES| 2:1 16:1 19:1 32:1 48:1 107:1 115:1 130:1 171:1 178:1 245:1 331:1 450:1 616:1 798:1 827:1 994:1 995:1 996:1 997:1 998:1 999:1  |EV| 
-4.1440327370637533022090792655945  |BT| (S (PP (IN (Among))(NP (ADJP (RB (frequently))(VBN (deleted)))(JJ (chromosomal))(NN (site))))(, (,))(NP (NN (LOH))(NN (chromosome))(NN (3p)))(VP (VBD (detected))(NP (NN (MM)))(, (,))(S (VP (VBG (suggesting))(S (NP (NN (presence)))(NP (CD (one))(NP (JJ (several))(NN (tumour))(NN (suppressor))(NN (gene))(JJ (important))(NN (role)))(NN (development))(NN (disease)))))))) |ET|  |BS| 12:Z01.542.049 15:F01.829.316.616 206:G05.360.340.024.340.375.249 289:A11.284.187 290:G05.365.590.029.530 291:F03.625.421  |ES| 2:1 9:1 19:1 31:1 35:1 262:1 346:1 698:1 700:1 902:1 998:1 1000:1 1001:1 1002:1 1003:1 1004:1 1005:1 1006:1 1007:1 1008:1 1009:1 1010:1 1011:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (PP (IN (In))(NP (NN (summary))))(, (,))(NP (NN (colon))(NN (cancer))(NN (cell)))(VP (MD (may))(VP (VB (up-regulate))(NP (NN (Notch-1))(JJ (protective))(NN (mechanism))(NN (response))(NN (chemotherapy)))))) |ET|  |BS| 41:A11 150:Z01.542.248.960 151:E02.319  |ES| 2:1 18:1 19:1 20:1 94:1 113:1 162:1 244:1 490:1 491:1 492:1 493:1 494:1 495:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NNP (New))(NN (aspect))(JJ (clinicopathologic))(NN (oncogene))(NN (study)))(NP (CD (23))(JJ (pulmonary))(JJ (lymphoepithelioma-like))(NN (carcinoma)))) |ET|  |BS| 9:G05.360.340.024.340.375.500 182:A04.411 265:C04.557.470.200  |ES| 19:1 24:1 131:1 304:1 948:1 1412:1 1413:1 1414:1 1415:1 1416:1  |EV| 
-3.4207303070149919221876189112663  |BT| (S (S (VP (TO (To))(VP (VB (elucidate))(NP (JJ (pathogenic))(NN (role))(NN (MLL))(NN (fusion))(NN (protein))(NN (HOX))(NN (dysregulation))(NN (leukaemia))))))(, (,))(VP (VBD (generated))(NP (JJ (novel))(JJ (haematopoietic))(JJ (lineage-specific))(NN (Mll-Een))(NN (knock-in))(NN (mouse))(NN (model)))(S (VP (VBG (using))(NP (JJ (Cre-mediated))(NN (inversion))(NN (strategy))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 15:F01.829.316.616 30:Z01.058.290.190.800 31:D08.811.520.224.800 259:D12.776.395.240.150.500 327:G06.930 361:C04.557.337 475:C23.550.210.190 476:A15.378  |ES| 2:1 4:1 19:1 31:1 52:1 72:1 73:1 350:1 828:1 891:1 936:1 1114:1 1202:1 1204:1 1207:1 1263:1 1697:1 1698:1 1699:1 1700:1 1701:1 1702:1 1703:1 1704:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (PRP$ (Our))(VP (VBP (result))(S (NP (NN (offer))(JJ (preclinical))(NN (rationale)))(VP (VBG (warranting))(NP (NP (JJ (clinical))(NN (investigation)))(VP (VBG (combining))(NP (NNS (HDACi))(NN (EGFR))(JJ (HER2-targeted))(NN (therapy))(NN (CRC))(NN (treatment)))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 52:E02 63:G05.360.340.024.340.375.500.791.295.305 65:D08.811.913.696.620.682.725.400.009.400 225:E05.337  |ES| 19:1 84:1 101:1 130:1 187:1 245:1 505:1 546:1 658:1 1042:1 1494:1 1495:1 1496:1 1497:1 1498:1 1499:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (SPDEF)))(VP (VP (VBD (inhibited))(NP (NN (expression))(JJ (beta-catenin-target))(NN (gene))(NN (mouse))(NN (colon))(NN (tumor))))(, (,))(VP (VBD (interacted))(NP (NP (NN (beta-catenin))(NN (block))(JJ (transcriptional))(NN (activity)))(NP (NN (CRC))(NN (cell))(NN (line))))(, (,))(S (VP (VBG (resulting))(NP (JJR (lower))(NN (level))(NN (cyclin))(NN (D1))(NN (c-MYC)))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 11:B01.050.150.900.649.865.635.505.500 23:D12.776.091.249 30:Z01.058.290.190.800 31:D08.811.520.224.800 51:C04.588.274.476.411.307.180 94:A11.251.210 122:C14.280.383 155:G05.355.310 209:G02.111.087.847 215:D12.644.360.262.150.100  |ES| 2:1 7:1 9:1 19:1 52:1 60:1 94:1 113:1 115:1 117:1 245:1 249:1 264:1 365:1 384:1 399:1 559:1 625:1 739:1 740:1 741:1 742:1 743:1 744:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NNS (CONCLUSIONS))(: (:)))(PP (IN (In))(NP (JJ (human))(NN (CRC))(NN (cell))))(, (,))(NP (NN (miR-221))(NN (miR-222)))(VP (VBP (act))(NP (JJ (positive))(NN (feedback))(NN (loop))(NN (increase))(NN (expression))(NN (level))(NN (RelA))(NN (STAT3))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 30:Z01.058.290.190.800 31:D08.811.520.224.800 41:A11 55:B01.050.150.900.649.801.400.112.400.400 81:E02.095.465.425.400.330.050.400 82:D12.644.360.024.342.300 83:L01.143.283.425  |ES| 2:1 19:1 36:1 40:1 94:1 104:1 115:1 140:1 141:1 233:1 239:1 244:1 245:1 246:1 247:1 248:1 249:1 250:1 251:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NP (ADVP (RB (Surprisingly)))(, (,))(VBN (given))(VBN (proposed))(NN (role))(NN (loss))(NN (function))(NN (mutation))(NN (p53))(NN (gene))(NN (development)))(NP (JJ (human))(JJ (colorectal))(NN (cancer)))(, (,)))(VP (VBD (found))(NP (NP (NN (evidence)))(PP (CC (either))(NP (NP (NN (increase))(NN (rate))(NN (adenoma))(NN (formation))(NN (APC)))(CC (+))(: (/))(: (-))(, (,))(NP (NN (p53))(: (-)))(: (/))(FRAG (: (-))(NP (NP (NN (animal)))(, (,))(NP (NP (VBD (increased))(NN (rate))(NN (progression))(NN (malignancy)))(VP (VBN (compared))(NP (NP (NN (APC)))(NP (CC (+))(: (/))(: (-))(NN (p53))(CC (+))(FRAG (: (/))(CC (+))(NP (NN (mouse))))))))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 11:B01.050.150.900.649.865.635.505.500 12:Z01.542.049 13:D01.339.387 14:F01.525 15:F01.829.316.616 16:C23.550.291.656 17:C04.557.470.035 18:G05.365.590 19:B01.050 20:G03.495  |ES| 2:1 9:1 11:1 12:1 17:1 18:1 19:1 28:1 29:1 30:1 31:1 32:1 33:1 34:1 35:1 36:1 37:1 38:1 39:1 40:1 41:1 42:1 43:1 44:1 45:1 46:1 47:1 48:1 49:1 50:1 51:1 52:1  |EV| 
4.6457201581691007774566060106736  |BT| (FRAG (SBAR (IN (Although))(S (NP (JJ (incomplete))(JJ (intestinal))(NN (metaplasia)))(ADVP (RB (morphologically)))(VP (VBZ (resembles))(NP (NP (NN (colon)))(, (,))(NP (NN (CDX2))(NN (expression))))(NP (ADJP (RB (apparently))(JJR (lower)))(JJ (normal))(NN (colon))))))) |ET|  |BS| 46:A03.556.124.526.356 47:A03.556.124 48:C23.550.589  |ES| 2:1 19:1 107:1 108:1 109:1 110:1 111:1 112:1 113:1 114:1 115:1 116:1 117:1 118:1  |EV| 
4.6457201581691007774566060106736  |BT| (FRAG (ADVP (RB (Furthermore)))(, (,))(NP (NP (JJ (high))(NN (uniform))(NN (expression))(NN (CDX2)))(NP (NP (JJ (characteristic))(JJ (metastatic))(JJ (colorectal))(NN (cancer)))(, (,))(NP (ADJP (ADJP (JJ (weak)))(CC (and/or))(ADJP (JJ (focal))))(NN (CDX2))(NN (expression))(JJ (alert))(JJ (surgical))(NN (pathologist))(NN (possibility))(JJ (primary))(NN (lung))(NN (adenocarcinoma)))(, (,))(NP (ADVP (RB (especially)))(NN (presence))(NN (goblet))(NN (cell))(NN (morphology)))))) |ET|  |BS| 113:C04.697.650 114:J01.637.215 115:E04  |ES| 2:1 17:1 18:1 19:1 94:1 114:1 115:1 149:1 178:1 255:1 328:1 334:1 335:1 336:1 337:1 338:1 339:1 340:1 341:1 342:1 343:1 344:1 345:1 346:1 347:1 348:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (JJ (Knock-down))(NN (Prmt1))(JJ (insufficient))(JJ (reverse))(JJ (active))(NN (chromatin))(NN (status)))(VP (VBN (hypomethylated))(NP (NN (Hox))(NN (locus)))(, (,))(S (VP (VBG (suggesting))(S (NP (JJ (Prmt1-mediated))(NN (histone))(NN (arginine))(NN (methylation)))(VP (ADVP (RB (partially)))(NP (VBN (involved))(NP (NN (maintenance))(NN (Hox))(NN (expression))(JJ (leukaemic))(NN (cell)))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 36:G02.111.087.029.538 41:A11 188:N02.628 351:A17.360 397:A11.284.430.106.279.345.190.160.180 398:D12.125.068.050 399:D12.776.660.470  |ES| 2:1 19:1 81:1 94:1 115:1 197:1 377:1 416:1 503:1 774:1 939:1 1009:1 1063:1 1203:1 1343:1 1344:1 1345:1 1346:1 1347:1 1348:1 1349:1 1350:1 1351:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (DT (These)))(VP (VBP (result))(VP (VBP (implicate))(S (NP (NN (SPARC))(NN (promoter))(NN (methylation))(JJ (important))(NN (factor))(NN (tumorigenesis))(JJ (gastric))(NN (carcinoma)))(VP (VB (provide))(NP (NP (JJ (new))(NN (insight))(JJ (potential))(NN (use)))(NP (NNP (SPARC))(JJ (novel))(NN (biomarker))(JJ (potential))(JJ (clinical))(NN (importance))(JJ (human))(JJ (gastric))(NN (cancer))))))))) |ET|  |BS| 32:C04.697.098.500 33:C04.697.098 36:G02.111.087.029.538 37:D12.776.157.125.715 55:B01.050.150.900.649.801.400.112.400.400 70:A03.556.875.875 158:D23.101 259:D12.776.395.240.150.500 265:C04.557.470.200  |ES| 18:1 19:1 36:1 78:1 81:1 82:1 83:1 84:1 86:1 101:1 185:1 304:1 711:1 712:1 792:1 827:1 885:1 891:1 902:1 1141:1 1658:1 1659:1 1660:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (Alteration))(NN (Apc))(NN (gene)))(VP (VBN (shown))(NP (NP (NN (play))(JJ (important))(NN (role)))(JJ (PhIP-induced))(JJ (IQ-induced))(NN (rat))(NN (colon))(NN (carcinogenesis))))) |ET|  |BS| 3:C04.557.470.035.215.100 15:F01.829.316.616 18:G05.365.590 30:Z01.058.290.190.800 31:D08.811.520.224.800 33:C04.697.098 46:A03.556.124.526.356 79:I03.450.642.693 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700  |ES| 9:1 19:1 31:1 113:1 207:1 237:1 238:1 280:1 849:1 902:1 1838:1 1839:1 1840:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (JJ (Intestinal))(NN (metaplasia))(NN (dysplasia))(JJ (low))(NN (expression))(NN (CDX2)))(VP (MD (may))(VP (VB (serve))(NP (JJ (predictive))(NN (marker))(JJ (gastric))(NN (cancer)))))) |ET|  |BS| 47:A03.556.124 48:C23.550.589 158:D23.101  |ES| 18:1 19:1 86:1 110:1 114:1 115:1 203:1 204:1 491:1 531:1 532:1 533:1 534:1  |EV| 
-0.80433585208038493874482810497284  |BT| (S (S (VP (VBN (Taken))(ADVP (RB (together)))))(, (,))(NP (NNS (data)))(VP (VBP (suggest))(SBAR (S (NP (NN (SRC-3)))(VP (MD (may))(NP (JJ (important))(NN (oncogene))(JJ (therapeutic))(NN (target))(NN (lung))(NN (cancer)))))))) |ET|  |BS| 9:G05.360.340.024.340.375.500 52:E02  |ES| 2:1 18:1 19:1 24:1 160:1 328:1 491:1 541:1 793:1 796:1 902:1 1537:1 1538:1 1549:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NP (NN (Identification))(NN (trophinin))(NN (enhancer))(NN (cell))(NN (invasion))(JJ (prognostic))(NN (factor)))(JJ (early))(NN (stage))(NN (lung))(NN (cancer)))) |ET|  |BS| 41:A11 374:F01.393.446 375:Z01.639.100  |ES| 18:1 19:1 94:1 185:1 328:1 620:1 884:1 972:1 1128:1 1129:1 1265:1 1266:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (PP (IN (By))(NP (JJ (immunohistochemical))(NN (analysis))))(, (,))(NP (CD (20))(CD (38))(NN (case))(JJ (undifferentiated))(NN (type)))(VP (VBD (advanced))(NP (NP (NN (stomach))(NN (cancer))(NN (K-sam)))(JJ (positive)))(, (,))(PP (IN (whereas))(NP (NP (NN (none))(CD (11))(NN (case)))(SBAR (S (NP (VBN (differentiated))(JJ (intestinal))(NN (type)))(VP (VBD (revealed))(NP (NN (K-sam))(NN (staining)))))))))) |ET|  |BS| 47:A03.556.124 74:G04.299.151 232:D02.886.030.676.180  |ES| 2:1 18:1 19:1 109:1 233:1 275:1 372:1 543:1 661:1 782:1 801:1 803:1 804:1 934:1 997:1 1057:1 1167:1 1605:1 1868:1 1869:1 1870:1 1871:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NP (JJ (Antisense))(NNS (oligodeoxynucleotides))(JJ (human))(NN (superoxide))(NN (dismutase))(CD (2)))(CC (and/or))(NP (JJ (ectopic))(NN (bcl-2))(NN (overexpression))))(VP (VBD (avoided))(NP (NP (NNS (polyphenols)))(SBAR (S (NP (JJ (chemoradiotherapy-induced))(JJ (colorectal))(NN (cancer))(NN (elimination)))(VP (VBD (showed))(NP (NP (JJ (mangano-type))(NN (superoxide))(NN (dismutase))(NN (Bcl-2))(JJ (key))(NN (target))(JJ (molecular))(NN (mechanism)))(VP (VBN (activated))(NP (JJ (combined))(NN (application))(NN (t-PTER))(NNP (QUER))))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 54:G05.360.340.024.340.375.500.791.150 55:B01.050.150.900.649.801.400.112.400.400 56:D02.455.426.559.389.657.715 57:D13.695.578.424.450 58:D08.811.682.881 59:E02.186.079  |ES| 17:1 18:1 19:1 36:1 132:1 144:1 145:1 146:1 147:1 148:1 149:1 150:1 151:1 152:1 153:1 154:1 155:1 156:1 157:1 158:1 159:1 160:1 161:1 162:1 163:1 164:1 165:1 166:1 167:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (DT (A))(NN (TRAMP/COX))(CD (-2))(JJ (knockout))(NN (mouse))(NN (model)))(ADVP (RB (also)))(VP (VBD (generated))(VP (VB (determine))(NP (NN (effect))(NN (loss))(NN (COX-2))(NN (gene))(NN (prostate))(NN (tumorigenesis))(NN (TRAMP))(NN (mouse)))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 29:B01.050.050.136.500.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 32:C04.697.098.500 33:C04.697.098 34:A05.360.444.575  |ES| 5:1 9:1 19:1 32:1 52:1 69:1 70:1 71:1 72:1 73:1 74:1 75:1 76:1 77:1 78:1 79:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (DT (The))(NN (Tg737))(NN (gene)))(VP (VBD (investigated))(NP (JJ (gross))(NN (alteration))(NN (series))(NN (rodent/human))(NN (liver))(NN (tumor))(JJ (human))(JJ (tumorigenic))(NN (cell))(NN (line))))) |ET|  |BS| 6:G05.360.340.024.340 55:B01.050.150.900.649.801.400.112.400.400 94:A11.251.210 514:B01.050.150.900.649.865 515:C04.588.274.623  |ES| 7:1 9:1 19:1 36:1 94:1 264:1 403:1 691:1 836:1 951:1 1805:1 1806:1 1807:1 1808:1 1809:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (ADVP (RB (However)))(, (,))(NP (NP (JJ (molecular))(NN (detail)))(VP (VBG (underlying))(NP (NP (NN (miR-146a))(JJ (mediated))(NN (regulation))(NN (target))(NN (gene))(JJ (precise))(JJ (biological))(NN (function))(NN (cancer)))(, (,))(NP (NP (RB (especially))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-)))))))(VP (VBZ (remains))(ADJP (JJ (unclear))))) |ET|  |BS| 104:C04.557.470.200.025.255 140:G05.355.315 141:G16.100  |ES| 2:1 9:1 10:1 14:1 18:1 19:1 33:1 160:1 161:1 303:1 304:1 345:1 433:1 434:1 435:1 436:1 437:1 438:1 439:1 440:1 441:1 442:1 443:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NP (NP (NN (DDR2)))(PRN (-LRB- (-LRB-))(NP (NN (L63V)))(-RRB- (-RRB-))))(: (;))(NP (NP (NN (TP53)))(PRN (-LRB- (-LRB-))(NP (NN (L/L)))(-RRB- (-RRB-))))(NP (NN (mouse))))(VP (VBD (developed))(NP (NP (ADJP (RB (poorly))(VBN (differentiated)))(NN (lung))(NN (adenocarcinoma))(JJ (transgenic))(NN (animal)))(VP (VBN (analyzed))(NP (NN (latency))(CD (40))(CD (50))(NN (week))(NN (median))(NN (survival))(CD (67.5))(NN (week))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 74:G04.299.151 96:I03.784 352:B01.050.050.136  |ES| 10:1 14:1 19:1 46:1 52:1 217:1 255:1 274:1 285:1 328:1 368:1 582:1 783:1 1018:1 1162:1 1163:1 1164:1 1165:1 1166:1 1167:1 1168:1 1169:1 1170:1 1171:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (JJ (Dual))(JJ (therapeutic))(NN (effect))(NN (interferon-alpha))(NN (gene))(NN (therapy))(NN (rat))(JJ (hepatocellular))(NN (carcinoma))(NN (model))(NN (liver))(NN (cirrhosis)))) |ET|  |BS| 104:C04.557.470.200.025.255 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 356:D12.644.276.374.440.890.250 357:C06.552.630  |ES| 9:1 19:1 72:1 75:1 130:1 303:1 304:1 541:1 836:1 849:1 1197:1 1198:1 1199:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (Mir-660)))(VP (VBD (downregulated))(SBAR (S (NP (NN (lung))(NN (cancer))(NN (patient))(NN (replacement)))(VP (VBZ (inhibits))(NP (NP (NN (lung))(NN (tumorigenesis)))(VP (VBG (targeting))(NP (NN (MDM2-p53))(NN (interaction)))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 32:C04.697.098.500 33:C04.697.098 50:M01.643 122:C14.280.383 181:E04.936.494 182:A04.411  |ES| 18:1 19:1 78:1 120:1 328:1 426:1 613:1 614:1 615:1 616:1 617:1 618:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (S (NP (NN (Cdx2)))(VP (VBZ (induces))(NP (NN (differentiation))(JJ (intestinal))(JJ (epithelial))(NN (cell))(NN (vitro)))))(: (;))(S (ADVP (RB (therefore)))(, (,))(VP (VBD (sought))(VP (VB (establish))(SBAR (IN (whether))(S (NP (JJ (causal))(NN (relationship)))(VP (VBZ (exists))(NP (NN (Cdx2))(NN (activation))(JJ (intestinal))(NN (metaplasia)))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 47:A03.556.124 48:C23.550.589 73:N05.715.350.200 74:G04.299.151 75:A11.436  |ES| 2:1 19:1 94:1 109:1 110:1 127:1 213:1 214:1 215:1 216:1 217:1 218:1 219:1 220:1 221:1 222:1 223:1 224:1 225:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (DT (These)))(VP (VBP (result))(VP (VBP (suggest))(NP (NN (ERBB4))(ADJP (ADJP (JJ (novel)))(ADJP (JJ (therapeutic))))(NN (target))(NN (subset))(NN (CRC)))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 52:E02 259:D12.776.395.240.150.500  |ES| 19:1 101:1 160:1 245:1 541:1 792:1 796:1 891:1 1285:1 1679:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NP (NP (JJ (Altered))(NN (expression))(JJ (human))(NN (enhancer))(NN (filamentation))(CD (1)))(PRN (-LRB- (-LRB-))(NP (NP (NN (HEF1)))(: (;))(NP (ADJP (RB (also))(VBN (known)))(NN (NEDD9))(NN (Cas-L))))(-RRB- (-RRB-))))(NP (VBN (implicated))(NN (progression))(NN (melanoma))(, (,))(NN (breast))(, (,))(NN (CRC))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 10:A01.236 16:C23.550.291.656 55:B01.050.150.900.649.801.400.112.400.400 282:C04.557.465.625.650.510  |ES| 2:1 5:1 10:1 14:1 19:1 23:1 36:1 48:1 98:1 115:1 217:1 245:1 556:1 971:1 972:1 973:1 974:1 975:1 976:1 977:1 978:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NN (Overactivation))(NN (Wnt-beta-catenin))(NN (signaling)))(, (,))(PP (VBG (including))(NP (NP (NN (beta-catenin-TCF))(NN (target))(NN (gene))(NN (expression)))(, (,))(NP (NP (NN (hallmark))(JJ (colorectal))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (CRC)))(-RRB- (-RRB-))))(NP (NN (development)))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 23:D12.776.091.249 105:G02.149.115.800.925 155:G05.355.310  |ES| 2:1 9:1 10:1 14:1 17:1 18:1 19:1 35:1 115:1 160:1 195:1 245:1 561:1 1427:1 1500:1 1501:1 1502:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (miR-490-3p)))(VP (VBD (exhibited))(NP (NP (JJ (progressive))(NN (downregulation))(NN (gastritis)))(, (,))(NP (JJ (intestinal))(NN (metaplasia)))(, (,))(NP (NN (adenocarcinoma))(NN (H)))))) |ET|  |BS| 47:A03.556.124 48:C23.550.589 84:C04.557.470.200.025 85:G02.111.087.225 175:J01.897.280.500.269 179:D01.248.497.300.459.700 180:C06.405.205.697  |ES| 2:1 19:1 109:1 110:1 255:1 595:1 608:1 609:1 610:1 611:1 612:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (PP (IN (As))(NP (JJ (key))(NN (molecule))(NN (drive))(NN (progression))(NN (chemoresistance))(JJ (gastrointestinal))(NN (cancer))))(, (,))(NP (NP (NP (JJ (epidermal))(NN (growth))(NN (factor))(NN (receptor)))(PRN (-LRB- (-LRB-))(NP (NN (EGFR)))(-RRB- (-RRB-))))(NN (HER2)))(VP (VBP (become))(NP (JJ (efficacious))(NN (drug))(NN (target))(NN (setting))))) |ET|  |BS| 16:C23.550.291.656 63:G05.360.340.024.340.375.500.791.295.305 64:D08.811.913.696.620.682.725.400.009.300 65:D08.811.913.696.620.682.725.400.009.400 66:F01.658.293 67:D26  |ES| 2:1 10:1 14:1 18:1 19:1 48:1 102:1 159:1 160:1 168:1 180:1 181:1 182:1 183:1 184:1 185:1 186:1 187:1 188:1 189:1 190:1 191:1 192:1  |EV| 
-3.5113925693386818238650448620319  |BT| (S (NP (NP (NP (JJ (Comparative))(NN (analysis))(NN (expression))(JJ (Pathogenesis-Related))(CD (1))(-LRB- (-LRB-))(NN (P6))(-RRB- (-RRB-))(NN (gene)))(, (,))(NP (NN (marker))))(VP (VBD (induced))(NP (NP (NN (resistance))(NN (pathogen)))(, (,))(NP (NP (JJ (various))(NN (tissue))(NN (tomato))(NN (plant)))(VP (VBN (treated))(NP (NN (CF))(NN (root))))))))(VP (VBD (suggested))(SBAR (S (NP (NNP (B.))(JJ (thuringiensis-induced))(NN (defense))(NN (system)))(VP (VBD (activated))(NP (NP (NN (leaf)))(, (,))(NP (NN (stem)))(, (,))(NP (JJ (main))(NN (root))(NN (tissue)))(, (,))(NP (JJ (lateral))(NN (root))(NN (tissue))))))))) |ET|  |BS| 6:G05.360.340.024.340 52:E02 98:A10 158:D23.101 309:A18.024.937 323:B01.650.940.800.575.100.905.322 324:B01.650.940.800.575.100.905.322 325:Z01.058.290.100.140 326:A18.400 327:G06.930 328:B01.650 329:A14.549.167.900.750 330:A18.024.812  |ES| 2:1 9:1 10:1 14:1 19:1 98:1 115:1 163:1 272:1 412:1 534:1 593:1 661:1 925:1 1091:1 1092:1 1093:1 1094:1 1095:1 1096:1 1097:1 1098:1 1099:1 1100:1 1101:1 1102:1 1103:1 1104:1 1105:1 1106:1 1107:1 1108:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (Antagonism))(NN (miR-221))(NN (miR-222)))(VP (VBZ (reduces))(NP (NN (growth))(NN (colon))(NN (tumor))(NN (mouse))(NN (colitis))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 45:G07.700.320.249 51:C04.588.274.476.411.307.180 53:C06.405.205.265  |ES| 7:1 19:1 52:1 102:1 113:1 139:1 140:1 141:1 142:1 143:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (Expression))(NN (DRD2)))(VP (VBZ (Is))(SBAR (S (NP (VBN (Increased))(JJ (Human))(JJ (Pancreatic))(JJ (Ductal))(NN (Adenocarcinoma))(NNS (Inhibitors)))(VP (VBP (Slow))(NP (NN (Tumor))(NN (Growth))(NNS (Mice)))))))) |ET|  |BS| 8:C04 11:B01.050.150.900.649.865.635.505.500 55:B01.050.150.900.649.801.400.112.400.400 362:D12.776.543.750.069.300.400.500 363:C04.557.470.200.025.232.750 364:D27.505.696.377.450  |ES| 19:1 316:1 444:1 583:1 1210:1 1211:1 1212:1 1213:1 1214:1 1215:1 1216:1 1217:1 1218:1 1219:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NP (DT (The))(JJ (recombinant))(NN (plasmid)))(NP (VBN (transfected))(JJ (human))(ADJP (NN (lung))(NN (cancer))(NN (A549))(NN (cell))(JJ (liposome-mediated)))(NN (method))))) |ET|  |BS| 41:A11 55:B01.050.150.900.649.801.400.112.400.400 168:E05.581 456:D25.479.517 457:G05.360.600  |ES| 18:1 19:1 36:1 94:1 328:1 364:1 479:1 691:1 1420:1 1597:1 1598:1 1599:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (DT (A))(JJ (previous))(NN (investigation)))(VP (VBD (indicated))(NP (NP (NN (ATA))(JJ (effective))(VBG (inhibiting))(NN (growth))(NN (breast))(NN (cancer)))(NP (RB (especially))(NN (cell))(NN (HER2))(NN (overexpression)))))) |ET|  |BS| 41:A11 45:G07.700.320.249 63:G05.360.340.024.340.375.500.791.295.305 65:D08.811.913.696.620.682.725.400.009.400 122:C14.280.383 225:E05.337 520:C10.228.140.252.190.530.060  |ES| 18:1 19:1 23:1 69:1 94:1 102:1 152:1 188:1 345:1 880:1 1497:1 1541:1 1639:1 1819:1 1820:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (Downregulation))(NN (miR-610)))(VP (VBZ (promotes))(SBAR (S (NP (NN (proliferation))(NN (tumorigenicity)))(VP (VBZ (activates))(NP (NN (Wnt/beta-catenin))(NN (signaling))(JJ (human))(JJ (hepatocellular))(NN (carcinoma)))))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 85:G02.111.087.225 104:C04.557.470.200.025.255 105:G02.149.115.800.925  |ES| 19:1 36:1 195:1 296:1 297:1 298:1 299:1 300:1 301:1 302:1 303:1 304:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (Analysis))(JJ (colorectal))(NN (cancer))(NN (patient))(NN (cohort)))(VP (VBZ (establishes))(SBAR (S (NP (NN (HNF4alpha)))(ADVP (RB (significantly)))(VP (VBD (upregulated))(NP (VBN (compared))(NP (JJ (adjacent))(JJ (normal))(JJ (epithelial))(NN (resection))))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 49:E05.318.760.500.750 50:M01.643  |ES| 17:1 18:1 19:1 50:1 118:1 119:1 120:1 121:1 122:1 123:1 124:1 125:1 126:1 127:1 128:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (DT (The))(JJ (significant))(NN (link))(NN (tobacco))(NN (loss))(NN (p16))(NN (locus)))(VP (VBZ (identifies))(NP (JJ (additional))(JJ (genetic))(NN (target))(NN (smoking))(NN (pathogenesis))(NN (lung))(NN (cancer))))) |ET|  |BS| 203:G05.360.340.024.340.375.249.375 459:B01.650.940.800.575.100.905.900 460:B01.650.940.800.575.100.905.900 461:F01.145.958.500 462:J01.637.836  |ES| 18:1 19:1 32:1 135:1 160:1 328:1 377:1 501:1 691:1 864:1 980:1 1313:1 1608:1 1609:1 1610:1 1611:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (Animal))(NN (breast))(NN (colon))(NN (tumor))(NN (therapy))(NN (study)))(VP (VBD (showed))(SBAR (S (NP (JJ (15-PGDH))(NN (gene))(NN (therapy)))(VP (VBD (produced))(NP (JJ (significant))(NN (delay))(NN (2LMP))(NN (LS174T))(NN (tumor))(NN (growth)))))))) |ET|  |BS| 8:C04 10:A01.236 19:B01.050 45:G07.700.320.249 51:C04.588.274.476.411.307.180 52:E02  |ES| 7:1 9:1 19:1 23:1 102:1 113:1 129:1 130:1 131:1 132:1 133:1 134:1 135:1 136:1 137:1 138:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NN (Methylation))(NN (rate))(NN (SPARC))(NN (gene)))(NP (NP (CD (80))(NN (%)))(NP (CD (ten))(JJ (gastric))(NN (cancer))(NN (cell))(NN (line)))(NP (NP (CD (74))(NN (%)))(PRN (-LRB- (-LRB-))(NP (CD (163))(CD (220)))(-RRB- (-RRB-))))(NP (JJ (primary))(NN (tumor))))(, (,))(NP (NP (ADJP (CD (5))(NN (%)))(JJ (normal))(JJ (gastric))(NN (mucosa)))(PRN (-LRB- (-LRB-))(S (NP (NN (n)))(VP (JJ (=))(NP (CD (40)))))(-RRB- (-RRB-))))) |ET|  |BS| 8:C04 36:G02.111.087.029.538 37:D12.776.157.125.715 94:A11.251.210 171:E05.318.308.985.775.500 172:A03.556.875.875.440 173:C07.465.864.500  |ES| 2:1 7:1 9:1 10:1 14:1 18:1 19:1 41:1 82:1 86:1 94:1 118:1 264:1 344:1 369:1 572:1 573:1 574:1 575:1 576:1 577:1 578:1 579:1 580:1 581:1 582:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (S (NP (JJ (K-ras))(NN (gene))(NN (mutation)))(VP (VBZ (enhances))(NP (NN (motility))(VBN (immortalized))(NN (airway))(NN (cell))(NN (lung))(NN (adenocarcinoma))(NN (cell)))(PP (IN (via))(NP (NN (Akt))(NN (activation)))))(: (:)))(NP (JJ (possible))(NN (contribution))(JJ (non-invasive))(NN (expansion))(NN (lung))(NN (adenocarcinoma))))) |ET|  |BS| 18:G05.365.590 41:A11 378:D08.811.913.696.620.682.700.755  |ES| 9:1 19:1 34:1 94:1 104:1 225:1 255:1 328:1 596:1 1121:1 1177:1 1289:1 1356:1 1357:1 1358:1 1359:1 1360:1 1361:1 1362:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (DT (All))(NN (fusion)))(VP (VBD (identified))(SBAR (S (NP (NP (NNP (RET))(NN (KIF5B))(NN (gene)))(, (,))(NP (NP (NNP (RET))(NN (fusion))(NN (CCDC6))(NN (NCOA4))(NN (gene)))(, (,))(NP (JJ (characteristic))(NN (thyroid))(NN (cancer)))(, (,))))(VP (VBD (identified))(NP (JJ (irradiated))(NN (lung))(NN (cell)))))))) |ET|  |BS| 6:G05.360.340.024.340 13:D01.339.387 41:A11 182:A04.411 281:E02.815  |ES| 2:1 9:1 18:1 19:1 94:1 328:1 336:1 623:1 936:1 956:1 965:1 966:1 967:1 968:1 969:1 970:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (K-Ras))(NN (mutation))(NN (treatment))(NN (outcome))(JJ (colorectal))(NN (cancer))(NN (patient)))(VP (VBG (receiving))(NP (JJ (exclusive))(NN (fluoropyrimidine))(NN (therapy))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 18:G05.365.590 50:M01.643 52:E02 164:E01.789.800  |ES| 13:1 17:1 18:1 19:1 34:1 120:1 130:1 546:1 547:1 548:1 549:1 550:1  |EV| 
4.6457201581691007774566060106736  |BT| (FRAG (NP (S (NP (NP (NNS (Mice))(NN (mutation))(NN (mismatch))(NN (repair))(NN (gene)))(, (,))(NP (NN (Msh2))(NN (Mlh1)))(, (,)))(VP (VBP (exhibit))(S (NP (NN (mismatch))(NN (repair))(NN (defect)))(VP (VBN (predisposed))(S (VP (VBG (developing))(NP (JJ (gastrointestinal))(NN (cancer)))))))))(, (,))(NN (lymphoma))(NN (tumor))(NN (organ))(NN (system)))) |ET|  |BS| 6:G05.360.340.024.340 8:C04 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 174:G02.111.087.219.220 175:J01.897.280.500.269 176:C04.557.386  |ES| 2:1 7:1 9:1 18:1 19:1 34:1 183:1 513:1 583:1 584:1 585:1 586:1 587:1 588:1 589:1 590:1 591:1 592:1 593:1  |EV| 
-4.6457201581691007774566060106736  |BT| (FRAG (PP (IN (In))(NP (NN (conclusion))))(, (,))(NP (NP (VBN (defined))(NN (subset))(NN (bone))(JJ (soft))(NN (tissue))(NN (tumor)))(, (,))(PP (VBG (including))(NP (JJ (benign))(NN (tumor))))(, (,))(S (NP (NN (Akt)))(ADVP (RB (frequently)))(VP (VBN (overexpressed))(S (VP (VBN (activated))))))(, (,))(NP (NP (NNP (AKT1/2))(NN (copy))(NN (number)))(VP (VBN (increased)))))) |ET|  |BS| 378:D08.811.913.696.620.682.700.755 379:C04.588.839 380:A02.835.232 381:C04  |ES| 2:1 7:1 19:1 25:1 47:1 163:1 244:1 272:1 561:1 646:1 680:1 698:1 963:1 1284:1 1285:1 1286:1 1287:1 1288:1 1289:1 1290:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (HEF1)))(VP (MD (may))(VP (VB (represent))(NP (NP (JJ (attractive))(NN (candidate))(NN (drug)))(VP (VBG (targeting))(NP (NN (CRC)))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 12:Z01.542.049 369:E02.319.300  |ES| 19:1 191:1 245:1 491:1 616:1 799:1 974:1 1242:1 1243:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NP (DT (A))(JJ (novel))(NN (GSK-3))(NN (beta-C/EBP))(JJ (alpha-miR-122-insulin-like))(NN (growth))(NN (factor))(CD (1))(NN (receptor))(JJ (regulatory))(NN (circuitry)))(NP (JJ (human))(JJ (hepatocellular))(NN (carcinoma))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 104:C04.557.470.200.025.255 259:D12.776.395.240.150.500 518:D08.811.913.696.620.682.725.400.185 519:D05.500.117.875  |ES| 19:1 36:1 69:1 98:1 102:1 185:1 186:1 303:1 304:1 891:1 1814:1 1815:1 1816:1 1817:1 1818:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (JJ (Stable))(NN (transfection))(NN (Ha-ras))(JJ (human))(NN (colon))(NN (cancer))(NN (line))(NN (CaCo2)))(VP (VBP (result))(NP (JJ (morphologic))(NN (differentiation))(JJ (small))(NN (bowel))(NN (phenotype))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 55:B01.050.150.900.649.801.400.112.400.400 74:G04.299.151 80:G05.695 216:Z01.107.084.900.425 217:E05.393.350.810 218:A03.556.124.684  |ES| 18:1 19:1 36:1 101:1 113:1 215:1 236:1 264:1 745:1 746:1 747:1 748:1 749:1 750:1 751:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (ADVP (RB (Interestingly)))(, (,))(NP (NP (NP (JJ (gastric))(NN (adenocarcinoma)))(ADJP (RB (significantly))(JJ (frequent)))(NN (Pdx-1-Cre)))(: (;))(NP (NN (Smad4))(-LRB- (-LRB-))(NN (F/F))(-RRB- (-RRB-)))(: (;))(NP (NN (Trp53))(-LRB- (-LRB-))(NN (F/F))(-RRB- (-RRB-)))(: (;))(NP (NP (NP (NN (Cdh1))(-LRB- (-LRB-))(NN (F))(-RRB- (-RRB-)))(PRN (-LRB- (-LRB-))(: (/))(CC (+))(-RRB- (-RRB-))))(NN (mouse))(NN (Pdx-1-Cre)))(: (;))(NP (NN (Smad4))(-LRB- (-LRB-))(NN (F/F))(-RRB- (-RRB-)))(: (;))(NP (NN (Trp53))(-LRB- (-LRB-))(NN (F/F))(-RRB- (-RRB-)))(: (;))(NP (NN (Cdh1))(PRN (-LRB- (-LRB-))(CC (+))(: (/))(CC (+))(-RRB- (-RRB-)))(NN (mouse)))(, (,))(S (NP (VBG (demonstrating))(NN (Cdh1))(NN (heterozygosity)))(VP (VBZ (accelerates))(NP (NN (development))(NN (progression))(JJ (gastric))(NN (adenocarcinoma)))))(, (,))(NP (NN (combination))(NN (loss))(NN (Smad4))(NN (p53)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 11:B01.050.150.900.649.865.635.505.500 16:C23.550.291.656 70:A03.556.875.875 84:C04.557.470.200.025 118:D01.248.497.158.380 157:G05.380.383  |ES| 2:1 10:1 12:1 14:1 19:1 32:1 35:1 48:1 51:1 52:1 86:1 124:1 217:1 255:1 518:1 519:1 520:1 521:1 522:1 523:1 524:1 525:1 526:1 527:1 528:1 529:1 530:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (ADVP (RB (Similarly)))(, (,))(NP (NN (treatment))(JJ (human))(NN (colon))(NN (cancer))(NN (cell))(NN (line))(NN (hypomethylating))(NN (agent)))(VP (VBZ (induces))(NP (NP (JJ (differentiation-related))(NN (gene)))(, (,))(PP (VBG (including))(NP (NN (CDX1))))))) |ET|  |BS| 6:G05.360.340.024.340 52:E02 55:B01.050.150.900.649.801.400.112.400.400 74:G04.299.151 94:A11.251.210  |ES| 2:1 9:1 18:1 19:1 36:1 94:1 113:1 214:1 264:1 546:1 561:1 726:1 727:1 728:1 729:1 730:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (CDX2))(NN (expression)))(VP (ADVP (RB (significantly)))(VBD (decreased))(NP (NP (JJ (incomplete))(JJ (intestinal))(NN (metaplasia)))(, (,))(NP (VBP (express))(NP (NP (JJ (gastric))(NN (mucin)))(PRN (-LRB- (-LRB-))(NP (NN (MUC5AC))(NN (MUC6)))(-RRB- (-RRB-))))(JJ (intestinal))(NP (NP (NN (mucin)))(PRN (-LRB- (-LRB-))(NP (NN (MUC2)))(-RRB- (-RRB-)))))(, (,)))(VP (VBD (compared))(NP (JJ (complete))(JJ (intestinal))(NN (metaplasia))))(, (,))(S (VP (VBP (express))(NP (NP (JJ (intestinal))(NN (mucin)))(PRN (-LRB- (-LRB-))(NP (NN (MUC2)))(-RRB- (-RRB-)))))))) |ET|  |BS| 47:A03.556.124 48:C23.550.589 71:D12.776.395.560.631 72:D12.776.395.560.631.100  |ES| 2:1 10:1 14:1 19:1 50:1 86:1 108:1 109:1 110:1 114:1 115:1 124:1 172:1 202:1 208:1 209:1 210:1 211:1 212:1  |EV| 
-4.3546499197312869000597856938839  |BT| (S (NP (NNS (METHODS))(: (:)))(NP (NP (JJ (Aberrant))(NN (methylation))(NN (status))(NN (p16))(NN (promoter))(NN (region)))(, (,))(NP (NN (expression))(NN (product)))(, (,))(NP (NP (NN (loss))(NN (heterozygosity)))(PRN (-LRB- (-LRB-))(NP (NN (LOH)))(-RRB- (-RRB-))))(NP (NN (9p21))))(VP (VBD (examined))(NP (NP (NP (ADJP (RB (surgically))(JJ (resected)))(NN (lung))(NN (specimen))(CD (57))(NN (patient)))(PRN (-LRB- (-LRB-))(NP (CD (28))(JJ (male))(CD (29))(NN (female)))(-RRB- (-RRB-))))(S (NP (JJ (peripheral-type))(NN (lung))(NN (adenocarcinoma)))(VP (VBG (measuring))(NP (ADVP (JJR (<))(: (/)))(NP (JJ (=))(CD (2))(NN (cm))(NN (diameter))))))))) |ET|  |BS| 36:G02.111.087.029.538 50:M01.643 115:E04 168:E05.581 182:A04.411 196:G02.111.570.080.689.675 203:G05.360.340.024.340.375.249.375 228:E05.978 290:G05.365.590.029.530  |ES| 2:1 10:1 14:1 19:1 32:1 80:1 81:1 83:1 104:1 115:1 120:1 148:1 255:1 312:1 324:1 326:1 328:1 416:1 528:1 565:1 667:1 675:1 1004:1 1154:1 1312:1 1313:1 1399:1 1400:1 1401:1 1402:1 1403:1 1404:1 1405:1 1406:1 1407:1 1408:1 1409:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (Cyclooxygenase-2))(NN (inhibitor)))(VP (VBP (down-regulate))(NP (NN (osteopontin))(NN (Nr4A2-new))(JJ (therapeutic))(NN (target))(JJ (colorectal))(NN (cancer))))) |ET|  |BS| 4:C04.588.274.476.411.307 52:E02 349:D27.505.519.389.310.500 350:D12.644.276.374.625 351:A17.360  |ES| 17:1 18:1 19:1 160:1 380:1 541:1 1158:1 1159:1 1160:1 1161:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (PP (IN (In))(NP (NN (study))))(, (,))(VP (VBP (demonstrate))(S (NP (NP (NP (NN (histone))(NN (deacetylase))(NN (inhibitor)))(PRN (-LRB- (-LRB-))(NP (NN (HDACi)))(-RRB- (-RRB-))))(NN (vorinostat))(NN (LBH589)))(VP (ADVP (RB (significantly)))(VBP (downregulate))(NP (NN (TS))(NN (gene))(NN (expression))(NN (panel))(NN (colon))(NN (cancer))(NN (cell))(NN (line))))))) |ET|  |BS| 94:A11.251.210 153:D27.505.519.389.360 154:Z01.058.266.887 155:G05.355.310  |ES| 2:1 9:1 10:1 14:1 18:1 19:1 94:1 113:1 115:1 124:1 131:1 244:1 264:1 380:1 502:1 503:1 504:1 505:1 506:1 507:1 508:1 509:1 510:1  |EV| 
4.6457201581691007774566060106736  |BT| (FRAG (ADVP (RB (Here)))(, (,))(NP (NP (NN (report))(ADJP (RB (inversely))(JJ (related)))(NN (expression))(NN (miR-137))(NN (CAR))(JJ (parental))(JJ (doxorubicin-resistant))(NN (neuroblastoma))(NN (cell)))(, (,))(SBAR (WHADVP (WRB (wherein)))(S (NP (NN (miR-137)))(VP (VBD (downregulated))(NP (JJ (resistant))(NN (cell)))))))) |ET|  |BS| 41:A11 136:D02.455.426.559.847.562.050.200.175 137:C04.557.465.625.600.590.650.550 138:F01.829.263.500.320 139:J01.937.500.100  |ES| 2:1 19:1 94:1 115:1 400:1 417:1 418:1 419:1 420:1 421:1 422:1 423:1 424:1 425:1 426:1 427:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NP (NN (Immunohistochemistry))(NN (beta-catenin)))(, (,))(NP (NN (c-myc)))(, (,))(NP (NP (NN (Ki-67))(NN (TUNEL-staining)))(VP (VBN (performed))(VP (VBP (investigate))(NP (NP (NN (TQ))(POS ('s)))(NN (effect))(JJ (major))(JJ (colorectal))(NN (cancer))(NN (pathway)))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 23:D12.776.091.249 30:Z01.058.290.190.800 31:D08.811.520.224.800 143:E01.370.225.500.607.512 144:E05.393.475  |ES| 2:1 17:1 18:1 19:1 60:1 75:1 383:1 454:1 455:1 456:1 457:1 458:1 459:1 460:1 461:1 462:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NNS (Mutations))(NN (EGFR))(NN (gene)))(VP (VBD (detected))(NP (NP (JJ (pulmonary))(NN (adenocarcinoma)))(PRN (-LRB- (-LRB-))(NP (NNS (ADCs)))(-RRB- (-RRB-)))))) |ET|  |BS| 18:G05.365.590 358:G05.360.340.024.340.375.500.791.295.300  |ES| 9:1 10:1 14:1 19:1 187:1 255:1 948:1 1007:1 1410:1 1411:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (DT (This))(NN (study)))(VP (VBP (show))(SBAR (S (NP (NN (c-Myc))(JJ (critical))(JJ (Apc-dependent))(JJ (intestinal))(NN (tumorigenesis))(NN (mouse)))(VP (VBZ (provides))(NP (JJ (potential))(JJ (therapeutic))(NN (target))(NN (treatment))(JJ (colorectal))(NN (cancer)))))))) |ET|  |BS| 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 11:B01.050.150.900.649.865.635.505.500 32:C04.697.098.500 33:C04.697.098 47:A03.556.124 52:E02  |ES| 17:1 18:1 19:1 52:1 78:1 109:1 131:1 160:1 429:1 541:1 546:1 807:1 815:1 824:1 825:1 826:1 827:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (Expression))(NN (KLK13))(NN (KLK14))(NN (gene)))(VP (VBN (examined))(NP (NP (NN (mRNA))(NN (protein))(NN (level))(NN (cohort))(CD (57))(NN (patient)))(NP (NP (JJ (non-small-cell))(NN (lung))(NN (cancer)))(PRN (-LRB- (-LRB-))(NP (NN (NSCLC)))(-RRB- (-RRB-))))))) |ET|  |BS| 6:G05.360.340.024.340 50:M01.643 110:C04.588.894.797.520.109.220.249 111:D13.444.735.544 112:D12.776.097.820  |ES| 4:1 9:1 10:1 14:1 18:1 19:1 120:1 121:1 249:1 316:1 322:1 323:1 324:1 325:1 326:1 327:1 328:1 329:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (IHH))(NN (SMO)))(VP (MD (may))(SBAR (S (NP (JJ (useful))(NNS (biomarkers))(JJ (diffuse))(NN (cancer)))(VP (MD (may))(VP (VB (show))(NP (NN (growth))(NN (inhibition))(NN (Hh))(NN (antagonist))(NN (cyclopamine))))))))) |ET|  |BS| 43:F01.145.544 45:G07.700.320.249 376:D23.101.140  |ES| 18:1 19:1 102:1 103:1 429:1 491:1 653:1 1036:1 1267:1 1268:1 1269:1 1270:1 1271:1 1272:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NP (DT (The))(NN (expression))(JJ (gastric))(NN (cancer))(NN (marker))(NN (MUC1)))(, (,))(NP (NN (MUC2)))(, (,))(NP (NN (MUC5AC)))(, (,))(NP (NN (oncogene))(NN (c-myc)))(, (,))(NP (NN (c-met)))(, (,))(NP (NN (cyclin))(NN (E1)))(, (,))(NP (NN (cancer))(NN (stem))(NN (cell))(NN (marker))(NN (CD44)))(VP (VBD (determined))(NP (NN (MGCC3I))(NN (cell)))))) |ET|  |BS| 41:A11 158:D23.101 332:A11.872.650  |ES| 2:1 18:1 19:1 24:1 86:1 94:1 115:1 210:1 212:1 455:1 534:1 691:1 743:1 1106:1 1578:1 1579:1 1580:1 1581:1 1582:1 1583:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NP (NN (Activation))(JJ (p53-dependent))(NN (apoptosis))(JJ (acute))(NN (ablation))(NN (glycogen))(NN (synthase))(NN (kinase-3beta)))(NP (JJ (colorectal))(NN (cancer))(NN (cell))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 38:Z01.058.290.120.180 39:G04.299.139.160 40:Z01.542.248.700 41:A11  |ES| 17:1 18:1 19:1 66:1 87:1 88:1 89:1 90:1 91:1 92:1 93:1 94:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (ADJP (RB (Here))(VBN (investigated)))(NP (NN (role))(NN (Bcl-3))(NN (azoxymethane/dextran))(NN (sulfate))(NN (sodium)))(PRN (-LRB- (-LRB-))(NP (NN (AOM/DSS)))(-RRB- (-RRB-))))(: (-))(VP (VBN (induced))(NP (NP (NN (colon))(NN (tumor)))(, (,))(NP (NN (mouse))(NN (model))(JJ (colitis-associated))(JJ (colorectal))(NN (cancer)))(JJ (human))))) |ET|  |BS| 4:C04.588.274.476.411.307 11:B01.050.150.900.649.865.635.505.500 15:F01.829.316.616 51:C04.588.274.476.411.307.180 53:C06.405.205.265 55:B01.050.150.900.649.801.400.112.400.400 131:D09.698.365.272.300 132:D02.172.080  |ES| 2:1 7:1 10:1 14:1 17:1 18:1 19:1 31:1 36:1 52:1 72:1 113:1 400:1 403:1 404:1 405:1 406:1 407:1 408:1 409:1 410:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (ADVP (RB (Here)))(, (,))(VP (VBD (investigated))(NP (NP (NN (cell))(NN (death))(NN (signaling))(NN (mechanism)))(VP (VBD (induced))(NP (NN (PGG))(JJ (human))(NN (prostate))(NN (cancer))(NN (cell))(JJ (different))(NN (p53))(JJ (functional))(NN (status))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 41:A11 55:B01.050.150.900.649.801.400.112.400.400 69:G02.111.087.800 133:D01.248.497.158.685.750.744.600 134:G04.299.139 135:C23.550.260  |ES| 2:1 12:1 18:1 19:1 36:1 77:1 94:1 162:1 195:1 400:1 403:1 411:1 412:1 413:1 414:1 415:1 416:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (PRP (We)))(VP (VBP (describe))(ADVP (RB (herein)))(SBAR (S (NP (NP (CD (eight))(RB (morphologically))(JJ (distinctive))(JJ (renal))(NN (tumor)))(VP (VBG (occurring))(NP (JJ (young))(NNS (people)))))(VP (VBP (bear))(NP (NP (JJ (identical))(NN (ASPL-TFE3))(NN (fusion))(NN (transcript))(NN (ASPS)))(, (,))(FRAG (NP (NN (distinction)))(-LRB- (-LRB-))(NP (NP (NN (X))(: (;))(CD (17))(-RRB- (-RRB-))(NN (translocation)))(ADJP (RB (cytogenetically))(JJ (balanced)))(JJ (renal))(NN (tumor)))))))))) |ET|  |BS| 274:C04.588.945.947.535 455:B01.050.150.900.649.147.890 463:C23.550.210.870 493:M01  |ES| 2:1 7:1 10:1 14:1 19:1 111:1 217:1 843:1 922:1 923:1 928:1 929:1 930:1 935:1 936:1 937:1 1525:1 1590:1 1618:1 1735:1 1736:1 1737:1 1738:1 1739:1 1740:1 1741:1 1742:1 1743:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (NP (JJ (Acute))(NN (ablation))(NN (GSK3beta))(JJ (colorectal))(NN (cancer))(NN (cell)))(VP (VBZ (activates))(NP (JJ (p53-dependent))(NN (apoptosis)))))(SBAR (S (VP (VBZ (antagonizes))(NP (NN (tumor))(NN (growth)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 8:C04 39:G04.299.139.160 41:A11 45:G07.700.320.249  |ES| 7:1 17:1 18:1 19:1 88:1 89:1 91:1 94:1 102:1 104:1 239:1 301:1 794:1 1893:1 1894:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (Amplification))(NN (over-expression))(NN (MAP3K3))(NN (gene))(JJ (human))(NN (breast))(NN (cancer)))(VP (VBZ (promotes))(NP (NN (formation))(NN (survival))(NN (breast))(NN (cancer))(NN (cell))))) |ET|  |BS| 20:G03.495 55:B01.050.150.900.649.801.400.112.400.400 108:G04.299.316 155:G05.355.310  |ES| 9:1 18:1 19:1 23:1 36:1 43:1 94:1 274:1 298:1 1012:1 1013:1 1014:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (S (VP (VBG (Using))(NP (NP (JJ (Mll-Een-expressing))(JJ (leukaemic))(NN (cell))(NN (line)))(VP (VBN (derived))(S (NP (NP (NN (bone))(NN (marrow))(NN (Mll))(-LRB- (-LRB-))(NN (Een))(-RRB- (-RRB-)))(PRN (-LRB- (-LRB-))(: (/))(CC (+))(-RRB- (-RRB-))))(VP (JJ (mutant))(NP (NN (mouse)))))))))(, (,))(VP (VBD (showed))(NP (NP (NN (induction))(NN (Hox))(NN (gene))(JJ (leukaemic))(NN (cell)))(VP (VBN (associated))(NP (NP (JJ (hypomethylated))(NN (promoter))(NN (region)))(NP (JJ (aberrant))(JJ (active))(NN (chromatin))(NN (state))(NN (Hox))(NN (locus)))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 12:Z01.542.049 41:A11 94:A11.251.210 196:G02.111.570.080.689.675 397:A11.284.430.106.279.345.190.160.180 487:G05.355.315.800 488:A15.382.216  |ES| 2:1 9:1 10:1 14:1 19:1 52:1 83:1 94:1 132:1 169:1 197:1 264:1 377:1 526:1 667:1 736:1 811:1 1203:1 1286:1 1346:1 1347:1 1348:1 1719:1 1720:1 1721:1 1722:1 1723:1 1724:1 1725:1 1726:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NN (Regulation))(NN (tumor))(NN (suppressor))(NN (homeogene))(NN (Cdx2))(NN (HNF4alpha))(JJ (intestinal))(NN (cancer)))) |ET|  |BS| 38:Z01.058.290.120.180 40:Z01.542.248.700 101:C04.588.274.476.411 142:I01.880.604 206:G05.360.340.024.340.375.249  |ES| 7:1 18:1 19:1 109:1 123:1 213:1 699:1 700:1 701:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (JJ (Sonic))(NN (hedgehog))(NN (inhibitor)))(VP (VBP (prevent))(NP (JJ (colitis-associated))(NN (cancer)))(FRAG (IN (via))(NP (VBN (orchestrated))(NN (mechanism))(NN (IL-6)))(: (/))(NP (NP (NN (gp130))(NN (inhibition)))(, (,))(NP (NN (15-PGDH))(NN (induction)))(, (,))(NP (NN (Bcl-2))(NN (abrogation)))(, (,))(NP (NN (tumorsphere))(NN (inhibition))))))) |ET|  |BS| 43:F01.145.544 53:C06.405.205.265 54:G05.360.340.024.340.375.500.791.150 201:D12.644.276.374.465.224 214:B01.050.150.900.649.473.376  |ES| 2:1 18:1 19:1 103:1 133:1 158:1 162:1 380:1 410:1 596:1 731:1 732:1 733:1 734:1 735:1 736:1 737:1 738:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NN (Methylation))(NN (TFPI2))(NN (stool))(NN (DNA)))(: (:))(NP (JJ (potential))(JJ (novel))(NN (biomarker))(NN (detection))(JJ (colorectal))(NN (cancer)))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 36:G02.111.087.029.538 158:D23.101 198:D13.444.308 259:D12.776.395.240.150.500 355:A12.459  |ES| 17:1 18:1 19:1 104:1 572:1 666:1 827:1 885:1 891:1 1023:1 1184:1 1185:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (HDAC8))(NN (STAT3)))(VP (VBP (repress))(NP (NN (BMF))(NN (gene))(NN (activity))(NN (colon))(NN (cancer))(NN (cell))))) |ET|  |BS| 6:G05.360.340.024.340 9:G05.360.340.024.340.375.500 41:A11 46:A03.556.124.526.356 82:D12.644.360.024.342.300  |ES| 9:1 18:1 19:1 94:1 113:1 251:1 396:1 397:1 398:1 399:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NNS (Aberrations))(NP (NP (NP (JJ (fragile))(NN (histidine))(NN (triad)))(PRN (-LRB- (-LRB-))(NP (NN (FHIT)))(-RRB- (-RRB-))))(NN (gene))(JJ (idiopathic))(JJ (pulmonary))(NN (fibrosis)))) |ET|  |BS| 6:G05.360.340.024.340 276:C08.381.483.487.500 277:D12.125.072.329  |ES| 9:1 10:1 14:1 19:1 942:1 943:1 944:1 945:1 946:1 947:1 948:1 949:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (ADVP (RB (Moreover)))(, (,))(NP (JJ (gastric))(NN (cancer))(JJ (human)))(ADVP (RB (often)))(VP (VBD (preceded))(NP (NP (JJ (intestinal))(NN (metaplasia)))(, (,))(NP (NN (phenotype))))(S (VP (VBD (described))(SBAR (S (ADVP (RB (strongly)))(VP (VBZ (suggests))(NP (NP (NN (involvement))(NN (Cdx2))(NN (initiation))(NN (process)))(VBG (leading))(JJ (intestinal))(NN (neoplasia))(JJ (gastric))(NN (mucosa)))))))))) |ET|  |BS| 47:A03.556.124 48:C23.550.589 55:B01.050.150.900.649.801.400.112.400.400 80:G05.695 86:D01.268.556.435 190:C04.588.274.476.767 191:A03.556.124.369  |ES| 2:1 18:1 19:1 36:1 86:1 109:1 110:1 213:1 236:1 331:1 579:1 622:1 632:1 633:1 634:1 635:1 636:1 637:1 638:1 639:1 640:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(S (NP (PRP$ (Our))(NN (result)))(VP (VB (identify))(NP (NP (NP (JJ (novel))(NN (candidate))(NN (mouse))(NN (gene)))(, (,))(NP (NN (Zfp277)))(, (,)))(SBAR (WHNP (WP$ (whose))(NN (expression))(NN (pattern)))(S (NP (JJ (compatible))(NN (role)))(VP (VBG (mediating))(NP (JJ (divergent))(NN (effect))(NN (Chrm3))(NN (Chrm1))(NN (gene))(NN (ablation))(JJ (murine))(JJ (intestinal))(NN (neoplasia)))))))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 15:F01.829.316.616 47:A03.556.124 102:C04.588.274.476.411 259:D12.776.395.240.150.500 537:G05.360.340.024.340.375  |ES| 2:1 9:1 19:1 31:1 52:1 75:1 91:1 101:1 104:1 109:1 115:1 239:1 260:1 627:1 640:1 658:1 761:1 832:1 891:1 919:1 1243:1 1895:1 1896:1 1897:1 1898:1 1899:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (Hypermethylation))(NN (miR-137))(NN (promoter))(JJ (negative))(NN (regulation))(NN (miR-137))(NN (CAR)))(VP (VP (VBP (contribute))(NP (NP (NN (part)))(VP (VBD (reduced))(NP (NN (miR-137))(NN (expression))))))(VP (VBD (increased))(NP (NN (CAR))(NN (MDR1))(NN (expression))(JJ (doxorubicin-resistant))(NN (neuroblastoma))(NN (cell)))))) |ET|  |BS| 41:A11 136:D02.455.426.559.847.562.050.200.175 137:C04.557.465.625.600.590.650.550 139:J01.937.500.100 142:I01.880.604  |ES| 19:1 47:1 83:1 94:1 115:1 420:1 421:1 423:1 424:1 438:1 448:1 449:1 450:1 451:1 452:1 453:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (JJ (Aldo-keto))(NN (reductase))(NN (family))(CD (1))(NN (B10))(NN (gene))(NN (silencing)))(VP (VBP (result))(NP (NP (NN (growth))(NN (inhibition))(JJ (colorectal))(NN (cancer))(NN (cell)))(: (:))(NP (NP (NN (Implication))(NN (cancer)))(NN (intervention)))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 41:A11 42:G05.355.315.203.374 43:F01.145.544 44:F01.829.263 45:G07.700.320.249  |ES| 9:1 17:1 18:1 19:1 94:1 95:1 96:1 97:1 98:1 99:1 100:1 101:1 102:1 103:1 104:1 105:1 106:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NP (NNS (Mice)))(VP (VBG (lacking))(NP (NN (MAT1A)))))(VP (VBD (reduced))(NP (JJ (hepatic))(NN (S-adenosylmethionine))(NN (content))(NN (hyperplasia)))(ADVP (RB (spontaneously)))(VP (VB (develop))(NP (JJ (nonalcoholic))(NN (steatohepatitis)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 232:D02.886.030.676.180 509:C06.552.241.519 510:C23.550.444  |ES| 19:1 376:1 452:1 583:1 648:1 838:1 1506:1 1791:1 1792:1 1793:1 1794:1 1795:1 1796:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (S (VP (VBG (Crossing))(NP (NP (NP (NN (Apc)))(PRN (-LRB- (-LRB-))(NP (NN (Delta14)))(: (/))(CC (+))(-RRB- (-RRB-))))(NP (NP (NN (mouse))(JJ (prone))(JJ (spontaneous))(JJ (intestinal))(NN (tumor))(NN (development))(NN (pCdx2-9LacZ)))(NP (JJ (transgenic))(NN (mouse))(S (VP (VBG (containing))(NP (NN (LacZ))(NN (reporter))(NN (control))(JJ (9.3-kb))(NN (Cdx2))(NN (promoter))))))))))(VP (VBD (showed))(SBAR (S (NP (NN (promoter))(NN (segment)))(VP (VBZ (contains))(NP (NP (NN (sequence)))(VP (VBG (recapitulating))(NP (NN (decrease))(NN (Cdx2))(NN (expression))(JJ (intestinal))(NN (cancer)))))))))) |ET|  |BS| 3:C04.557.470.035.215.100 11:B01.050.150.900.649.865.635.505.500 26:G02.111.570.080 99:B01.050.050.136.500 100:G05.360.340.024.686.545 101:C04.588.274.476.411 102:C04.588.274.476.411 103:G11.427.695.525  |ES| 7:1 10:1 14:1 18:1 19:1 35:1 52:1 83:1 109:1 115:1 132:1 213:1 279:1 280:1 281:1 282:1 283:1 284:1 285:1 286:1 287:1 288:1 289:1 290:1 291:1 292:1 293:1 294:1 295:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (ADVP (RB (Here)))(, (,))(NP (VBD (generated))(NN (mouse))(NN (model))(NN (lung))(NN (adenocarcinoma)))(VP (VBN (driven))(NP (NP (NN (mutation))(NN (discoidin))(NN (domain))(NN (receptor))(CD (2))(-LRB- (-LRB-))(NN (DDR2))(-RRB- (-RRB-))(NN (gene)))(JJ (combined))(NN (loss))(NN (TP53))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 66:F01.658.293  |ES| 2:1 9:1 10:1 14:1 19:1 32:1 34:1 52:1 72:1 73:1 148:1 164:1 186:1 255:1 328:1 400:1 920:1 1018:1 1162:1 1173:1 1245:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (PP (IN (In))(NP (NN (addition))))(, (,))(NP (NN (PIM))(NN (kinase)))(VP (VBP (activate))(S (NP (NN (MYC))(NN (signaling))(NN (mRNA))(NN (translation))(NN (prostate))(NN (cancer)))(VP (VBP (cooperate))(S (NP (NN (MYC)))(VP (VB (accelerate))(NP (NN (tumorigenesis))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 32:C04.697.098.500 33:C04.697.098 69:G02.111.087.800 145:G02.111.087.675.871  |ES| 2:1 18:1 19:1 77:1 78:1 195:1 244:1 325:1 468:1 469:1 470:1 471:1 472:1 473:1 474:1 475:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (CRC))(NN (xenograft)))(VP (VBD (differed))(NP (NP (NP (NP (NN (p53))(NN (status)))(PRN (-LRB- (-LRB-))(NP (JJ (wt))(NN (muf)))(-RRB- (-RRB-))))(NN (microsatellite))(NN (instability))(NN (phenotype)))(PRN (-LRB- (-LRB-))(NP (NP (NN (MSI)))(CC (+))(NP (JJ (altered))))(-RRB- (-RRB-)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 80:G05.695 92:E04.936.764 93:A01.941.875 538:C23.550.362.590  |ES| 10:1 12:1 14:1 19:1 236:1 245:1 265:1 416:1 693:1 1299:1 1332:1 1901:1 1902:1 1903:1 1904:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (JJ (Preneoplastic))(JJ (neoplastic))(NNS (hepatocytes)))(VP (VBP (undergo))(NP (NN (c-Myc))(NN (up-regulation))(NN (overgrowth))(NN (rat)))(NP (NP (RB (genetically))(JJ (susceptible))(NN (hepatocarcinogenesis)))(, (,))(NP (JJ (resistant))(NN (rat)))))) |ET|  |BS| 8:C04 142:I01.880.604 245:B01.050.150.900.649.865.635.505.700 246:B01.050.150.900.649.865.635.505.700 261:C23.550.291.687.500 262:A11.436.348  |ES| 2:1 19:1 427:1 824:1 849:1 892:1 893:1 894:1 895:1 896:1 897:1 898:1 899:1 900:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NN (Expression))(JJ (gut-enriched))(JJ (Kruppel-like))(NN (factor)))(FRAG (-LRB- (-LRB-))(NP (NP (JJ (Kruppel-like))(NN (factor))(CD (4))(-RRB- (-RRB-))(NN (gene)))(JJ (human))(ADJP (NN (colon))(NN (cancer))(NN (cell))(NN (line))(NN (RKO))(JJ (dependent)))(NN (CDX2))))) |ET|  |BS| 6:G05.360.340.024.340 9:G05.360.340.024.340.375.500 46:A03.556.124.526.356 55:B01.050.150.900.649.801.400.112.400.400 94:A11.251.210  |ES| 9:1 10:1 14:1 18:1 19:1 36:1 94:1 113:1 114:1 185:1 264:1 316:1 317:1 318:1 319:1 320:1 321:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (DT (These)))(VP (VBP (result))(NP (VBN (suggested))(NN (PSMA6))(NN (serf))(JJ (attractive))(NN (target))(JJ (high))(JJ (therapeutic))(NN (index))(NN (lung))(NN (cancer))))) |ET|  |BS| 52:E02  |ES| 18:1 19:1 101:1 160:1 178:1 328:1 541:1 721:1 792:1 882:1 925:1 1242:1 1682:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NNS (CONCLUSIONS))(: (:)))(UCP (PP (IN (In))(NP (NN (mouse))))(, (,))(NP (NP (NN (fucosylation))(NN (deficiency))(NN (lead))(NN (colitis))(NN (adenocarcinoma)))(, (,))(NP (NN (loss))(NN (Notch))(NN (activation)))(, (,))(NP (NN (down-regulation))(NN (Hes1)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 53:C06.405.205.265 84:C04.557.470.200.025 85:G02.111.087.225 86:D01.268.556.435 87:C18.654.521  |ES| 2:1 19:1 32:1 52:1 104:1 143:1 225:1 239:1 244:1 252:1 253:1 254:1 255:1 256:1 257:1 258:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NP (JJ (Mammary))(NN (tumour)))(NP (VBN (observed))(NN (EphB4))(JJ (transgenic))(NN (animal))))(: (;))(NP (ADVP (RB (however)))(, (,))(NP (NP (JJ (double))(JJ (transgenic))(NN (animal))(VBG (expressing))(NN (EphB4))(NN (neuT))(NN (gene)))(, (,))(NP (NN (tumour))(NN (appearance)))(S (S (ADVP (RB (significantly)))(VP (VBD (accelerated))))(, (,))(NP (NP (NN (contrast))(JJ (neuT-only))(NN (animal)))(, (,))(NP (NN (metastasis)))(NP (VBD (observed))(NN (lung)))))))) |ET|  |BS| 6:G05.360.340.024.340 8:C04 19:B01.050 113:C04.697.650 182:A04.411 352:B01.050.050.136 407:E01.370.225.812.735.550 408:C04.588.531  |ES| 2:1 9:1 19:1 46:1 124:1 217:1 261:1 285:1 328:1 806:1 810:1 1011:1 1379:1 1386:1 1387:1 1388:1 1389:1 1390:1 1391:1 1392:1 1393:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (miR-137)))(VP (VBZ (regulates))(SBAR (S (NP (JJ (constitutive))(NN (androstane))(NN (receptor)))(VP (VBZ (modulates))(NP (NN (doxorubicin))(NN (sensitivity))(JJ (parental))(JJ (doxorubicin-resistant))(NN (neuroblastoma))(NN (cell)))))))) |ET|  |BS| 41:A11 136:D02.455.426.559.847.562.050.200.175 137:C04.557.465.625.600.590.650.550 138:F01.829.263.500.320  |ES| 19:1 94:1 186:1 420:1 422:1 423:1 424:1 599:1 603:1 604:1 605:1 606:1 607:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (PP (IN (In))(NP (JJ (particular))))(, (,))(NP (NP (NN (expression))(JJ (intestine-specific))(NN (transcription))(NN (factor))(NN (Cdx2)))(, (,))(NP (JJ (key))(NN (gene))(JJ (intestinal))(NN (identity)))(VP (VBD (downregulated))(NP (NP (JJ (invasive))(NN (cancer))(NN (cell)))(, (,))(VP (VBD (reduced))(NP (NN (wound))(NN (healing))(NN (vitro))))))))) |ET|  |BS| 41:A11 47:A03.556.124 89:G16.100.856.891 149:G05.360.340.024.340.364.875.890  |ES| 2:1 9:1 18:1 19:1 94:1 109:1 115:1 159:1 185:1 213:1 216:1 244:1 267:1 268:1 426:1 452:1 485:1 486:1 487:1 488:1 489:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (PRP (We)))(VP (ADVP (RB (previously)))(VP (VBD (reported))(SBAR (S (NP (NN (kallistatin))(NN (gene))(NN (therapy)))(VP (VBD (suppressed))(NP (NP (NN (growth))(NN (HCC))(NN (tumor))(JJ (anti-angiogenic))(NN (activity)))(, (,))(NP (NN (meloxicam)))(, (,))(NP (JJ (selective))(NN (COX-2))(NN (inhibitor))))))))(, (,))(VP (VBD (inhibited))(NP (NN (proliferation))(JJ (induced))(NN (apoptosis))(JJ (human))(NN (HCC))(NN (cell))(NN (vitro)))))) |ET|  |BS| 8:C04 39:G04.299.139.160 41:A11 45:G07.700.320.249 55:B01.050.150.900.649.801.400.112.400.400 104:C04.557.470.200.025.255 122:C14.280.383 349:D27.505.519.389.310.500  |ES| 2:1 7:1 9:1 19:1 36:1 76:1 89:1 94:1 102:1 130:1 216:1 299:1 307:1 365:1 380:1 399:1 412:1 441:1 843:1 993:1 1088:1 1089:1 1527:1 1748:1 1749:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (S (NP (DT (The))(NN (aim))(NN (work)))(VP (VP (VB (evaluate))(SBAR (IN (whether))(S (NP (NN (TP53))(NN (mutation)))(VP (VBN (classified))(ADVP (RB (functionally)))(ADJP (JJ (inactive)))))))(PRN (-LRB- (-LRB-))(NP (ADJP (ADJP (JJR (<)))(CC (or))(ADJP (JJ (=))))(ADJP (CD (20))(NN (%)))(JJ (wildtype))(NN (transactivation))(NN (ability)))(-RRB- (-RRB-))))(S (NP (NP (JJ (different))(JJ (prognostic))(JJ (predictive))(NN (value))(NN (CRC)))(VBN (compared))(NN (mutation)))(VP (VBD (retained))(NP (JJ (significant))(NN (activity))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 18:G05.365.590 30:Z01.058.290.190.800 31:D08.811.520.224.800 225:E05.337 385:F02.784.629.131 395:L01.100 445:I03.946 454:G05.355.315.800  |ES| 10:1 14:1 19:1 34:1 50:1 135:1 221:1 245:1 312:1 369:1 399:1 414:1 533:1 691:1 884:1 890:1 1018:1 1248:1 1300:1 1546:1 1567:1 1571:1 1572:1 1573:1 1574:1 1575:1 1576:1 1577:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (SBAR (IN (Because))(S (NP (NN (Notch))(NN (signaling))(VBN (implicated))(NN (colon))(NN (cancer))(NN (tumorigenesis)))(VP (VBZ (protects))(NP (NP (NN (cell))(NN (apoptosis)))(VP (VBG (inducing))(NP (JJ (prosurvival))(NN (target))))))))(, (,))(VP (VBD (hypothesized))(SBAR (S (NP (NP (NN (inhibition))(NN (Notch))(NN (signaling))(NN (gamma-secretase))(NN (inhibitor)))(PRN (-LRB- (-LRB-))(NP (NN (GSI)))(-RRB- (-RRB-))))(VP (MD (may))(NP (VB (enhance))(NP (NN (chemosensitivity))(NN (colon))(NN (cancer))(NN (cell))))))))) |ET|  |BS| 32:C04.697.098.500 33:C04.697.098 39:G04.299.139.160 41:A11 43:F01.145.544 69:G02.111.087.800 125:D08.811.277.656.300.032  |ES| 2:1 10:1 14:1 18:1 19:1 78:1 89:1 94:1 103:1 113:1 160:1 195:1 256:1 380:1 386:1 491:1 977:1 1690:1 1750:1 1862:1 1863:1 1864:1 1865:1 1866:1 1867:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NP (NN (Overexpression))(NN (miR-141))(JJ (pancreatic))(NN (cancer))(NN (cell)))(VBD (inhibited))(NP (NN (cell))(NN (proliferation)))(, (,))(NP (NP (NN (clonogenicity)))(, (,))(NP (NN (invasion)))(: (;))(NP (VBN (induced))(NN (G1))(NN (arrest))(NN (apoptosis)))(: (;))(NP (VBN (enhanced))(NN (chemosensitivity)))))) |ET|  |BS| 39:G04.299.139.160 41:A11 122:C14.280.383 183:G04.299.233.750  |ES| 2:1 18:1 19:1 89:1 94:1 217:1 299:1 365:1 385:1 386:1 412:1 463:1 467:1 602:1 620:1 668:1 669:1 670:1  |EV| 
4.6457201581691007774566060106736  |BT| (FRAG (PP (IN (In))(NP (JJ (adult))))(, (,))(NP (NP (JJ (Cdx1))(NN (Cdx2)))(, (,))(NP (NN (Cdx4)))(, (,))(NP (ADJP (RB (intensively))(VBN (explored)))(NN (function))(JJ (intestinal))(NN (tissue))(NN (homeostasis))(NN (pathogenesis))(JJ (gastrointestinal))(NN (cancer))))) |ET|  |BS| 47:A03.556.124 98:A10 119:M01.060.116 152:G07.700.345  |ES| 2:1 18:1 19:1 33:1 109:1 183:1 213:1 244:1 272:1 355:1 496:1 497:1 498:1 499:1 500:1 501:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (Detection)))(VP (VBN (methylated))(S (NP (NN (BCL6B)))(VP (MD (may))(VP (VB (serve))(NP (JJ (independent))(NN (biomarker))(NN (prognosis))(NN (GC)))))))) |ET|  |BS| 36:G02.111.087.029.538 158:D23.101 163:E01.789  |ES| 19:1 491:1 532:1 544:1 554:1 883:1 885:1 1179:1 1180:1 1181:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NP (CD (One))(JJ (common))(JJ (rate-limiting))(NN (mutation)))(JJ (human))(NN (CRC)))(VP (VBZ (occurs))(NP (JJ (adenomatous))(NN (polyposis))(NN (coli))(-LRB- (-LRB-))(NN (APC))(-RRB- (-RRB-))(NN (gene))))) |ET|  |BS| 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 6:G05.360.340.024.340 21:G05.360.340.024.340.375.249.050 55:B01.050.150.900.649.801.400.112.400.400 194:G05.355.044.250.750  |ES| 9:1 10:1 11:1 14:1 19:1 34:1 36:1 57:1 58:1 59:1 245:1 654:1 655:1 656:1 657:1  |EV| 
-1.175290870094315209826163481921  |BT| (NP (NP (NN (EGFR))(NN (gene))(NN (mutation))(NN (ALK))(NN (gene))(NN (fusion))(JJ (well-characterized))(JJ (molecular))(NN (target))(NN (NSCLC)))) |ET|  |BS| 18:G05.365.590 110:C04.588.894.797.520.109.220.249 358:G05.360.340.024.340.375.500.791.295.300 359:G05.355.760.385  |ES| 9:1 19:1 34:1 160:1 161:1 187:1 329:1 936:1 962:1 1200:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NNS (CONCLUSIONS))(: (:)))(NP (NP (JJ (Gastric))(NN (expression))(NN (Cdx2)))(ADJP (RB (alone))(JJ (sufficient))))(VP (VBP (induce))(NP (JJ (intestinal))(NN (metaplasia))(NN (mouse))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 47:A03.556.124 48:C23.550.589 70:A03.556.875.875  |ES| 19:1 52:1 104:1 109:1 110:1 115:1 213:1 239:1 240:1 241:1 242:1 243:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (DT (The))(NN (aim))(NN (study)))(VP (VBD (determine))(SBAR (IN (whether))(S (S (VP (VBG (combining))(NP (NN (kallistatin))(NN (gene))(NN (therapy))(NN (meloxicam)))))(VP (MD (could))(VP (VB (offer))(NP (ADJP (ADJP (JJR (better)))(ADJP (JJ (therapeutic))))(NN (effect))(NN (combat))(NN (HCC))(NN (mouse))))))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 104:C04.557.470.200.025.255  |ES| 9:1 19:1 52:1 74:1 75:1 130:1 131:1 221:1 441:1 541:1 691:1 904:1 908:1 1042:1 1088:1 1089:1 1498:1 1567:1 1568:1  |EV| 
4.6457201581691007774566060106736  |BT| (FRAG (NP (ADVP (FW (In))(FW (vitro)))(PRN (, (,))(NP (NP (VBN (forced))(NN (expression))(NN (Cdx2))(JJ (human))(NN (colon))(NN (cancer))(NN (cell))(NN (line)))(SBAR (S (NP (VBN (retarded))(NN (wound))(NN (repair)))(VP (VBD (reduced))(NP (NN (migration)))))))(, (,))))(SBAR (IN (whereas))(S (NP (NN (inhibition))(NN (Cdx2))(NN (expression))(NN (RNA))(NN (interference)))(VP (VBD (enhanced))(NP (NN (migration))))))) |ET|  |BS| 43:F01.145.544 55:B01.050.150.900.649.801.400.112.400.400 89:G16.100.856.891 94:A11.251.210 122:C14.280.383 156:G05.355.315.203.374.790  |ES| 2:1 18:1 19:1 36:1 94:1 103:1 113:1 115:1 213:1 216:1 244:1 264:1 267:1 372:1 385:1 452:1 511:1 512:1 513:1 514:1 515:1 516:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (CONCLUSION))(: (:)))(NP (DT (These))(JJ (clinical))(JJ (mechanistic))(NN (finding)))(VP (VBP (indicate))(SBAR (S (NP (NP (NN (IFITM3))(JJ (direct))(JJ (transcriptional))(NN (target))(NN (KLF4)))(VBN (dysregulated))(NP (NN (KLF4)))(NN (expression)))(VP (VBP (lead))(NP (JJ (aberrant))(NN (IFITM3))(NN (expression)))(, (,))(S (ADVP (RB (thus)))(VP (VBG (contributing))(NP (NN (colon))(NN (cancer))(NN (progression))(NN (metastasis)))))))))) |ET|  |BS| 16:C23.550.291.656 86:D01.268.556.435 113:C04.697.650 209:G02.111.087.847  |ES| 2:1 18:1 19:1 48:1 84:1 104:1 113:1 115:1 160:1 254:1 559:1 696:1 792:1 806:1 927:1 1259:1 1295:1 1334:1 1479:1 1725:1 1882:1 1890:1 1891:1 1892:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (BACKGROUND))(: (:)))(NP (NN (MUC4))(VBN (cloned))(JJ (tracheobronchial))(NN (mucosa))(NN (cDNA)))(ADVP (RB (reportedly)))(ADVP (RB (highly)))(VP (VBN (expressed))(NP (NP (JJ (human))(NN (malignancy)))(, (,))(PP (VBG (including))(NP (NN (lung))(NN (carcinoma))))))) |ET|  |BS| 55:B01.050.150.900.649.801.400.112.400.400 182:A04.411 265:C04.557.470.200 300:D13.444.308.497.220 301:A11.251.353 302:A10.615.550  |ES| 2:1 6:1 19:1 36:1 49:1 104:1 304:1 328:1 561:1 579:1 626:1 1046:1 1047:1 1048:1 1049:1 1050:1 1051:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NNS (RESULTS))(: (:)))(S (PP (IN (In))(NP (NN (CRC))(NN (cell))(NN (line))))(, (,))(VP (VBP (mimic))(NP (NN (miR-221))(NN (miR-222))(VBD (activated))(NN (NF-kappaB))(NN (STAT3)))(, (,))(NP (VBG (increasing))(NN (expression))(NN (miR-221))(NN (miR-222)))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 82:D12.644.360.024.342.300 94:A11.251.210 210:D12.776.260.600  |ES| 2:1 19:1 94:1 104:1 115:1 140:1 141:1 163:1 244:1 245:1 251:1 264:1 567:1 710:1 714:1 715:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (PP (IN (In))(NP (JJ (nude))(NN (mouse))(NN (xenograft))(NN (model))))(, (,))(NP (NN (overexpression))(NN (miR-141))(NN (knockdown))(NN (MAP4K4)))(ADVP (RB (significantly)))(VP (VBD (repressed))(NP (JJ (pancreatic))(NN (cancer))(NN (cell))(NN (growth))))) |ET|  |BS| 41:A11 45:G07.700.320.249 88:B01.050.150.900.649.865.635.505.500.550.500 92:E04.936.764 93:A01.941.875  |ES| 2:1 18:1 19:1 52:1 72:1 94:1 102:1 124:1 152:1 244:1 265:1 266:1 463:1 464:1 465:1 466:1 467:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (PRP (It)))(ADJP (ADJP (RB (likely))(JJ (major)))(SBAR (S (NP (NN (genotype))(JJ (gastric))(NN (carcinoma)))(VP (VBD (placed))(NP (JJS (least))(CD (4))(NN (microsatellite))(NN (category)))(, (,))(S (ADVP (RB (thus)))(VP (VBG (allowing))(NP (NP (NN (construction))(JJ (comprehensive))(JJ (genetic))(NN (classification)))(JJ (useful))(NN (prediction))(JJ (diverse))(JJ (clinical))(NN (course)))))))))) |ET|  |BS| 70:A03.556.875.875 265:C04.557.470.200 394:G02.111.570.080.708.800.500 395:L01.100 396:G05.380  |ES| 2:1 19:1 84:1 86:1 304:1 319:1 462:1 864:1 1036:1 1327:1 1328:1 1329:1 1330:1 1331:1 1332:1 1333:1 1334:1 1335:1 1336:1 1337:1 1338:1 1339:1 1340:1 1341:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NP (NP (NN (Beta-catenin/T-cell))(NN (factor)))(PRN (-LRB- (-LRB-))(NP (NN (Tcf)))(-RRB- (-RRB-))))(NN (signaling)))(NP (RB (constitutively))(JJ (active))(NN (majority))(JJ (human))(JJ (colorectal))(NN (cancer)))(, (,))(VP (VBG (accompanying))(NP (NN (change))(NN (Bcl-2))(NN (expression))))) |ET|  |BS| 4:C04.588.274.476.411.307 23:D12.776.091.249 54:G05.360.340.024.340.375.500.791.150 55:B01.050.150.900.649.801.400.112.400.400 68:A11.118.637.555.567.569 69:G02.111.087.800  |ES| 2:1 10:1 14:1 17:1 18:1 19:1 36:1 115:1 158:1 185:1 193:1 194:1 195:1 196:1 197:1 198:1 199:1 200:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (ADVP (RB (Furthermore)))(, (,))(NP (NN (CD133))(NN (DNA))(NN (methylation)))(VP (VBZ (seems))(VP (VBP (constitute))(SBAR (S (NP (JJ (abnormal))(NN (promoter))(NN (signature)))(VP (VBD (found))(NP (NP (JJ (normal))(NN (brain))(NN (colon)))(VP (VBN (cultured))(NP (JJ (primary))(NN (tumor))))))))))) |ET|  |BS| 8:C04 30:Z01.058.290.190.800 31:D08.811.520.224.800 46:A03.556.124.526.356 366:G02.111.087.029.538.161 367:A08.186.211  |ES| 2:1 7:1 19:1 37:1 81:1 83:1 113:1 118:1 334:1 344:1 652:1 666:1 1227:1 1228:1 1229:1 1230:1 1231:1 1232:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NNS (METHODS))(: (:)))(NP (NP (NP (NN (CRC))(NN (cell))(NN (line)))(PRN (-LRB- (-LRB-))(NP (NN (HCT116))(NN (RKO)))(-RRB- (-RRB-))))(VP (VBN (transfected))(S (NP (NN (miR-221))(NN (miR-222)))(VP (VBP (mimic))(NP (NN (inhibitor)))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 94:A11.251.210 168:E05.581  |ES| 10:1 14:1 19:1 94:1 104:1 140:1 141:1 245:1 264:1 320:1 380:1 479:1 565:1 566:1 567:1  |EV| 
-0.40048764756708976619847817346454  |BT| (S (NP (VBG (Activating))(NP (NN (alteration))(NN (variety))(JJ (potential))(JJ (oncogenic))(NN (driver))(NN (gene))))(ADVP (RB (also)))(VP (VBD (identified))(NP (NP (NNP (NSCLC)))(, (,))(PP (VBG (including))(NP (NN (ROS1))))(, (,))(NP (NNP (RET)))(, (,))(NP (NN (MET)))(, (,))(NP (NN (HER2)))(, (,))(NP (NN (BRAF)))))) |ET|  |BS| 18:G05.365.590 63:G05.360.340.024.340.375.500.791.295.305 65:D08.811.913.696.620.682.725.400.009.400 110:C04.588.894.797.520.109.220.249 278:D08.811.913.696.620.682.700.559.842.374 279:D27.888.569.100  |ES| 2:1 5:1 9:1 19:1 188:1 329:1 561:1 623:1 827:1 950:1 951:1 952:1 953:1 954:1 955:1 956:1 957:1 958:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NP (NP (JJ (Human))(NN (CRC))(NN (tissue)))(NP (JJR (higher))(NN (level))(NN (miR-221))(NN (miR-222))(JJ (nontumor))(NN (colon))(NN (tissue))))(: (;))(NP (NN (increase)))(VP (VBD (correlated))(NP (VBN (increased))(NN (level))(NN (RelA))(NN (STAT3))(NNS (mRNAs)))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 46:A03.556.124.526.356 55:B01.050.150.900.649.801.400.112.400.400 82:D12.644.360.024.342.300 98:A10 111:D13.444.735.544  |ES| 19:1 40:1 47:1 113:1 140:1 141:1 170:1 217:1 245:1 249:1 250:1 251:1 272:1 444:1 445:1 446:1 447:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (gamma-Secretase))(NN (inhibitor)))(VP (VBP (abrogate))(NP (NP (JJ (oxaliplatin-induced))(NN (activation))(NN (Notch-1))(NN (signaling))(NN (pathway))(NN (colon))(NN (cancer))(NN (cell)))(VP (VBG (resulting))(NP (VBN (enhanced))(NN (chemosensitivity))))))) |ET|  |BS| 41:A11 69:G02.111.087.800 125:D08.811.277.656.300.032 126:G02.111.087.800  |ES| 18:1 19:1 20:1 94:1 113:1 195:1 225:1 379:1 380:1 381:1 382:1 383:1 384:1 385:1 386:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NNS (Alterations))(NP (NP (NN (hMSH2))(NN (gene)))(VP (VBN (linked))(NP (ADJP (QP (RB (approximately))(CD (60)))(NN (%)))(JJ (hereditary))(JJ (nonpolyposis))(NN (colon))(NN (cancer))(NN (case)))))) |ET|  |BS| 18:G05.365.590 30:Z01.058.290.190.800 31:D08.811.520.224.800 524:C04.588.274.476.411.307.190  |ES| 9:1 18:1 19:1 113:1 369:1 934:1 1363:1 1841:1 1842:1 1843:1 1844:1 1845:1 1846:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (p53))(NN (activation))(NN (CRC))(NN (cell)))(VP (VBD (interfered))(NP (JJ (IL-6-induced))(NN (invasion))(NN (migration)))(PP (IN (via))(NP (JJ (miR-34a-dependent))(NN (downregulation))(NN (IL6R))(NN (expression)))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 41:A11 85:G02.111.087.225 201:D12.644.276.374.465.224  |ES| 12:1 19:1 94:1 115:1 225:1 245:1 514:1 595:1 596:1 620:1 681:1 682:1 683:1 684:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NP (DT (The))(JJ (significant))(NN (association))(NN (SNIP1))(NN (c-Myc))(NN (staining))(JJ (non-small))(NN (cell))(NN (lung))(NN (cancer))(NN (tissue))(NN (array))(NN (evidence))(NN (activity)))(VP (MD (might))(VP (VBN (linked)))))(VP (VBZ (suggests))(SBAR (S (NP (NN (SNIP1)))(VP (MD (might))(NP (JJ (important))(NN (modulator))(NN (c-Myc))(NN (activity))(NN (carcinogenesis)))))))) |ET|  |BS| 12:Z01.542.049 33:C04.697.098 98:A10 110:C04.588.894.797.520.109.220.249 386:F02.463.425.069  |ES| 18:1 19:1 38:1 94:1 135:1 207:1 272:1 328:1 331:1 399:1 691:1 694:1 798:1 824:1 902:1 1298:1 1363:1 1604:1 1605:1 1606:1 1607:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (DT (These))(NNS (data))(NN (challenge))(NN (view))(NN (MYH11))(NN (passive))(NN (differentiation))(NN (marker)))(VP (VBG (functioning))(S (NP (NN (muscle))(NN (contraction)))(VP (VBP (add))(S (VP (VBG (understanding))(NP (JJ (intestinal))(NN (neoplasia))))))))) |ET|  |BS| 74:G04.299.151 102:C04.588.274.476.411 158:D23.101 239:F02.463.188.357 375:Z01.639.100 464:G11.427.590.540  |ES| 19:1 109:1 215:1 534:1 640:1 792:1 793:1 905:1 1371:1 1626:1 1627:1 1628:1 1629:1 1630:1 1631:1 1632:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (JJ (Further))(NN (decrease))(NN (CDX2))(NN (expression))(JJ (gastric))(NN (dysplasia))(NN (cancer)))(VP (VBZ (suggests))(NP (NP (NN (CDX2))(NN (play))(JJ (similar))(JJ (anticarcinogenic))(NN (role)))(JJ (intestinal))(NN (metaplasia))(NN (colon))))) |ET|  |BS| 15:F01.829.316.616 46:A03.556.124.526.356 47:A03.556.124 48:C23.550.589 70:A03.556.875.875 79:I03.450.642.693  |ES| 18:1 19:1 31:1 86:1 109:1 110:1 113:1 114:1 115:1 203:1 238:1 295:1 330:1 331:1 332:1 333:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (JJ (Testis-specific))(NN (Fank1))(NN (gene))(JJ (knockdown))(NN (mouse)))(VP (VBP (produce))(NP (NN (oligospermia)))(PP (IN (via))(NP (NN (apoptosis)))))) |ET|  |BS| 11:B01.050.150.900.649.865.635.505.500 39:G04.299.139.160 400:E05.393.335.500 451:C12.294.365.700.508 452:A05.360.444.849  |ES| 9:1 19:1 52:1 89:1 464:1 596:1 1563:1 1564:1 1565:1 1566:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NP (DT (A))(NP (NP (JJ (genetic))(NN (basis))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(JJ (well-established))(JJ (major))(NN (signaling))(NN (pathway)))(, (,))(NP (NP (NN (p53)))(, (,))(NP (NN (Wnt-signaling)))(, (,))(NP (NP (NP (VBG (transforming))(NN (growth))(NN (factor-beta)))(PRN (-LRB- (-LRB-))(NP (NN (TGF-beta)))(-RRB- (-RRB-))))(NN (Ras))(NN (pathway))))(, (,)))(VP (VBD (identified))(NP (JJ (essential))(NN (HCC))(NN (development))))) |ET|  |BS| 1:G05.360.340.024.340.375.500.791.550 2:G05.360.340.024.340.375.249.385 30:Z01.058.290.190.800 31:D08.811.520.224.800 69:G02.111.087.800 104:C04.557.470.200.025.255 126:G02.111.087.800 149:G05.360.340.024.340.364.875.890 503:D12.644.276.374.687  |ES| 2:1 10:1 12:1 14:1 19:1 35:1 69:1 102:1 195:1 303:1 304:1 383:1 441:1 462:1 623:1 864:1 1140:1 1770:1 1771:1 1772:1 1773:1 1774:1 1775:1 1776:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (LINE-1))(NN (methylation)))(VP (VBD (decreased))(SBAR (S (NP (NN (transition))(JJ (intestinal))(NN (metaplasia))(JJ (gastric))(NN (adenoma))(NN (decrease)))(VP (VBD (occurred))(NP (NN (transition))(JJ (gastric))(NN (adenoma))(NN (GC)))))))) |ET|  |BS| 17:C04.557.470.035 36:G02.111.087.029.538 47:A03.556.124 48:C23.550.589 70:A03.556.875.875  |ES| 19:1 42:1 81:1 86:1 109:1 110:1 202:1 295:1 551:1 552:1 553:1 554:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NP (NN (Incubation))(NN (CRC))(NN (cell))(NN (miR-221))(NN (miR-222))(NN (inhibitor)))(SBAR (S (NP (VBD (reduced))(NN (proliferation))(NN (colony))(NN (formation)))(VP (VBN (compared))(NP (NN (control))(NN (cell)))))))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 20:G03.495 41:A11 109:I01.696.116  |ES| 19:1 43:1 50:1 94:1 140:1 141:1 245:1 289:1 299:1 314:1 380:1 452:1 517:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (Astrocyte))(JJ (elevated))(NN (gene-1))(NN (c-Myc)))(VP (VBP (cooperate))(VP (VBP (promote))(NP (NN (hepatocarcinogenesis))(NN (mouse)))))) |ET|  |BS| 6:G05.360.340.024.340 11:B01.050.150.900.649.865.635.505.500 30:Z01.058.290.190.800 31:D08.811.520.224.800 529:A08.637.200  |ES| 19:1 52:1 474:1 679:1 756:1 824:1 900:1 1858:1 1859:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NP (NN (CDX2)))(, (,))(NP (NP (JJ (human))(NN (homologue)))(NP (FW (Drosophila))(FW (caudal))))(, (,)))(NP (VBN (mutated))(NN (allele))(NN (replication))(NN (error))(JJ (positive))(JJ (colorectal))(NN (cancer)))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 55:B01.050.150.900.649.801.400.112.400.400 76:B01.050.500.131.617.289.310.250 77:G05.360.340.024.340.030 78:G02.111.087.222  |ES| 2:1 17:1 18:1 19:1 36:1 114:1 226:1 227:1 228:1 229:1 230:1 231:1 232:1 233:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (CDX2))(NN (expression)))(ADVP (RB (progressively)))(VP (VBD (decreased))(NP (NP (JJ (human))(JJ (gastric))(JJ (intestinal))(NN (metaplasia)))(, (,))(NP (NN (dysplasia))(NN (cancer)))))) |ET|  |BS| 33:C04.697.098 47:A03.556.124 48:C23.550.589 55:B01.050.150.900.649.801.400.112.400.400 70:A03.556.875.875  |ES| 2:1 18:1 19:1 36:1 86:1 109:1 110:1 114:1 115:1 159:1 201:1 202:1 203:1 204:1 205:1 206:1 207:1  |EV| 
4.6457201581691007774566060106736  |BT| (NP (NP (NP (NN (PURPOSE))(: (:)))(NN (IFITM3))(, (,))(JJ (IFN-inducible))(NN (gene)))(, (,))(NP (VBN (overexpressed))(JJ (human))(JJ (colorectal))(NN (cancer)))) |ET|  |BS| 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 6:G05.360.340.024.340 55:B01.050.150.900.649.801.400.112.400.400  |ES| 2:1 9:1 17:1 18:1 19:1 25:1 36:1 104:1 687:1 696:1 697:1  |EV| 
4.6457201581691007774566060106736  |BT| (S (NP (NN (CDX2))(NN (expression)))(ADVP (RB (progressively)))(VP (VBD (decreased))(NP (NP (JJ (human))(JJ (gastric))(JJ (intestinal))(NN (metaplasia)))(, (,))(NP (NN (dysplasia))(NN (cancer)))))) |ET|  |BS| 47:A03.556.124 48:C23.550.589 55:B01.050.150.900.649.801.400.112.400.400 70:A03.556.875.875  |ES| 2:1 18:1 19:1 36:1 86:1 109:1 110:1 114:1 115:1 201:1 202:1 203:1  |EV| 
-0.81878830156630044712073868140578  |BT| (S (NP (NP (NN (Androgen))(JJ (receptor-induced))(NN (tumor))(NN (suppressor)))(, (,))(NP (NN (KLLN)))(, (,)))(VP (VBZ (inhibits))(SBAR (S (NP (NN (breast))(NN (cancer))(NN (growth)))(ADVP (RB (transcriptionally)))(VP (VBZ (activates))(NP (JJ (p53/p73-mediated))(NN (apoptosis))(NN (breast))(NN (carcinoma)))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 39:G04.299.139.160 45:G07.700.320.249 122:C14.280.383 206:G05.360.340.024.340.375.249 528:D12.776.826.750.150  |ES| 2:1 7:1 18:1 19:1 23:1 89:1 102:1 301:1 304:1 615:1 700:1 1478:1 1852:1 1853:1 1854:1 1855:1  |EV| 
-1.2722188884672505082562565803528  |BT| (S (S (VP (VBN (Taken))(ADVP (RB (together)))))(, (,))(NP (NNS (data)))(VP (VBD (suggested))(SBAR (S (NP (NN (ING5))(NN (downregulation)))(VP (MD (might))(VP (VBN (involved))(SBAR (S (NP (NP (NN (carcinogenesis)))(, (,))(NP (NN (growth)))(, (,))(NP (NN (invasion))(NN (lung))(NN (cancer))))(VP (MD (could))(VP (VBN (considered))(S (NP (JJ (promising))(NN (marker))(NN (gauge))(NN (aggressiveness))(NN (lung))(NN (cancer)))))))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 33:C04.697.098 45:G07.700.320.249 85:G02.111.087.225 158:D23.101 162:F01.145.126.125  |ES| 2:1 18:1 19:1 102:1 207:1 328:1 534:1 595:1 620:1 774:1 793:1 798:1 908:1 925:1 1061:1 1316:1 1517:1 1537:1 1538:1 1539:1 1540:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (JJR (Higher))(NN (frequency))(JJ (inactive))(NN (TP53))(NN (mutation)))(ADVP (RB (also)))(VP (VBN (seen))(S (NP (NP (NP (JJ (advanced))(NN (stage))(NN (tumour)))(PRN (-LRB- (-LRB-))(S (NP (NN (P)))(VP (JJ (=))(NP (CD (0.0003)))))(-RRB- (-RRB-))))(NN (tumour))(JJ (poor))(JJ (prognostic))(NN (feature)))(NP (ADJP (NP (JJ (vascular)))(PRN (-LRB- (-LRB-))(S (NP (NN (P)))(VP (JJ (=))(NP (CD (0.006)))))(-RRB- (-RRB-))))(NP (NP (JJ (lymphatic))(NN (invasion)))(PRN (-LRB- (-LRB-))(S (NP (NN (P)))(VP (JJ (=))(NP (CD (0.002)))))(-RRB- (-RRB-)))))))) |ET|  |BS| 8:C04 159:I01.880.735.634 194:G05.355.044.250.750 213:F02.830.816.964 370:A15.382.520.301 371:A07.231  |ES| 5:1 10:1 14:1 19:1 34:1 311:1 545:1 581:1 620:1 724:1 884:1 997:1 1011:1 1018:1 1129:1 1246:1 1247:1 1248:1 1249:1 1250:1 1251:1 1252:1 1253:1 1254:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (S (VP (TO (To))(VP (VB (determine))(SBAR (IN (whether))(S (NP (NP (NN (DAP))(NN (kinase))(NN (promoter)))(NN (methylation)))(VP (VBZ (contributes))(NP (NP (NN (TRAIL))(NN (resistance))(NN (NSCLC))(NN (cell)))(, (,))(NP (NP (VBN (measured))(NN (DAP))(NN (kinase))(NN (promoter))(NN (methylation))(NN (gene))(NN (expression))(NN (status)))(NP (CD (11))(NN (NSCLC))(NN (cell))(NN (line)))))))))))(VP (VBD (correlated))(NP (NN (methylation/expression))(NN (status))(NN (sensitivity))(NN (cell))(NN (TRAIL))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 36:G02.111.087.029.538 41:A11 94:A11.251.210 110:C04.588.894.797.520.109.220.249 155:G05.355.310 228:E05.978 474:D08.811.913.696.620.682.700.125.387  |ES| 2:1 9:1 19:1 74:1 81:1 83:1 94:1 115:1 221:1 264:1 329:1 416:1 446:1 470:1 607:1 789:1 828:1 845:1 1057:1 1094:1 1694:1 1695:1 1696:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (PRP (It)))(VP (VBD (suggested))(SBAR (S (NP (NN (ING5))(NN (expression)))(VP (MD (might))(VP (VP (VBN (employed))(S (NP (JJ (good))(NN (marker))(JJ (gastric))(NN (carcinogenesis))(JJ (subsequent))(NN (progression)))(VP (VBG (inhibiting))(NP (NN (proliferation))))))(, (,))(NP (NP (NN (growth)))(, (,))(NP (NN (migration)))(, (,))(NP (NN (invasion))(NN (metastasis)))))))))) |ET|  |BS| 16:C23.550.291.656 33:C04.697.098 45:G07.700.320.249 70:A03.556.875.875 113:C04.697.650 122:C14.280.383 158:D23.101  |ES| 2:1 19:1 48:1 86:1 102:1 115:1 207:1 299:1 514:1 534:1 620:1 798:1 806:1 880:1 925:1 1316:1 1318:1 1319:1 1327:1 1342:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (NP (NN (BACKGROUND)))(CC (&))(NP (NNS (AIMS))))(: (:))(S (NP (NP (NN (p53))(NNS (Mutations)))(JJ (common))(NP (JJ (human))(JJ (hepatocellular))(NN (carcinoma)))(, (,))(NP (NN (induction))(JJ (hepatic))(NN (p53))(NN (expression))))(VP (VBP (cause))(SBAR (S (NP (NN (lysis)))(VP (VBD (implanted))(NP (NN (hepatoblastoma))(NN (cell))(JJ (chimeric))(NN (mouse))))))))) |ET|  |BS| 2:G05.360.340.024.340.375.249.385 11:B01.050.150.900.649.865.635.505.500 18:G05.365.590 41:A11 55:B01.050.150.900.649.801.400.112.400.400 73:N05.715.350.200 104:C04.557.470.200.025.255 504:C04.557.435.380 505:B05.200  |ES| 2:1 12:1 19:1 36:1 52:1 94:1 104:1 115:1 303:1 304:1 655:1 736:1 838:1 1046:1 1410:1 1777:1 1778:1 1779:1 1780:1 1781:1 1782:1 1783:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (CRC)))(VP (VBD (initiated))(NP (NP (NN (mutation))(NN (tumor))(NN (suppressor))(NN (gene)))(, (,))(NP (JJ (adenomatous))(NN (polyposis))(NN (coli))(-LRB- (-LRB-))(NN (APC))(-RRB- (-RRB-))))(, (,))(NP (NN (beta-catenin))(NN (gene))))) |ET|  |BS| 3:C04.557.470.035.215.100 4:C04.588.274.476.411.307 5:C04.588.274.476.411.307 6:G05.360.340.024.340 18:G05.365.590 21:G05.360.340.024.340.375.249.050 23:D12.776.091.249 206:G05.360.340.024.340.375.249  |ES| 2:1 7:1 9:1 10:1 11:1 14:1 19:1 34:1 57:1 58:1 59:1 60:1 245:1 700:1 1900:1  |EV| 
-1.4641258020242275961209088563919  |BT| (S (NP (NN (OBJECTIVE))(: (:)))(VP (TO (To))(VP (VB (test))(SBAR (IN (whether))(S (NP (NP (NP (JJ (brain-targeted))(NN (gene))(NN (therapy))(JJ (recombinant))(JJ (adeno-associated))(NN (virus)))(PRN (-LRB- (-LRB-))(NP (NN (rAAV5)))(-RRB- (-RRB-))))(: (-))(NP (NN (IDUA))(NN (vector))(NN (MPS-I))(JJ (transgenic))(NN (mouse))(NN (model))))(VP (MD (would))(VP (VB (reverse))(NP (JJ (pathological))(NN (hallmark)))))))))) |ET|  |BS| 30:Z01.058.290.190.800 31:D08.811.520.224.800 99:B01.050.050.136.500 367:A08.186.211 412:C16.320.565.202.715.640 413:B04.280.580.650.170 414:B04.280.580.650.170 415:F01.658.500 416:G05.360.337 417:H02.403.650  |ES| 9:1 10:1 14:1 19:1 52:1 72:1 104:1 130:1 221:1 285:1 362:1 828:1 866:1 939:1 1417:1 1418:1 1419:1 1420:1 1421:1 1422:1 1423:1 1424:1 1425:1 1426:1 1427:1  |EV| 
-4.6457201581691007774566060106736  |BT| (NP (NP (JJ (Tubular))(NN (atrophy))(JJ (low))(NN (netrin-1))(NN (gene))(NN (expression)))(NP (VBN (associated))(VBN (delayed))(NN (kidney))(NN (allograft))(NN (function)))) |ET|  |BS| 155:G05.355.310 483:C23.300.070 484:A01.941.500 485:A05.810.453 486:E04.936.864  |ES| 9:1 19:1 33:1 115:1 169:1 531:1 1713:1 1714:1 1715:1 1716:1 1717:1 1718:1  |EV| 
-4.6457201581691007774566060106736  |BT| (S (NP (NN (HOX))(NN (gene)))(ADVP (RB (frequently)))(VP (VBN (dysregulated))(NP (NP (JJ (human))(NN (leukaemia))(NN (gene))(NN (rearrangement))(JJ (mixed))(NN (lineage))(NN (leukaemia)))(PRN (-LRB- (-LRB-))(NP (NN (MLL)))(-RRB- (-RRB-))))(NP (NN (partner))(NN (gene))))) |ET|  |BS| 6:G05.360.340.024.340 55:B01.050.150.900.649.801.400.112.400.400 229:G05.360.340.024.340.230.500 361:C04.557.337 373:G05.355.330  |ES| 9:1 10:1 14:1 19:1 36:1 698:1 1204:1 1207:1 1259:1 1260:1 1261:1 1262:1 1263:1 1264:1  |EV| 
-2.7669292123208606426487676799297  |BT| (S (S (NP (JJ (Ectopic))(NN (expression))(NN (miR-155)))(VP (VBD (promoted))(NP (NP (NP (NN (growth))(JJ (hepatocellular))(NN (carcinoma)))(PRN (-LRB- (-LRB-))(NP (NN (HCC)))(-RRB- (-RRB-))))(NN (cell)))))(, (,))(IN (whereas))(S (NP (NN (depletion)))(VP (VBD (inhibited))(NP (NN (cell))(NN (growth)))))) |ET|  |BS| 41:A11 45:G07.700.320.249 104:C04.557.470.200.025.255 107:G05.355.315.202 122:C14.280.383  |ES| 2:1 10:1 14:1 19:1 94:1 102:1 115:1 303:1 304:1 305:1 365:1 372:1 441:1 1613:1 1911:1 1912:1  |EV| 
-2.4316220031735156226204708218575  |BT| (NP (NP (DT (These))(UCP (S (VP (VBG (finding))(PP (VBN (suggested))(NP (NN (endostatin))(NN (gene))(NN (therapy))))(, (,))(S (VP (VBG (using))(NP (JJ (cationic))(JJ (vector-mediated))(JJ (intravenous))(NN (gene))(NN (transfer)))))))(, (,))(MD (might))(NP (NP (JJ (feasible))(NN (strategy))(JJ (organ-targeted))(NN (prevention))(NN (regulation)))(JJ (possible))(VBN (disseminated))(NN (cancer)))))) |ET|  |BS| 123:G05.360.337 142:I01.880.604 466:D12.644.276.100.450.750 467:D01.248.497.300  |ES| 2:1 9:1 18:1 19:1 130:1 350:1 438:1 792:1 798:1 925:1 927:1 1114:1 1359:1 1474:1 1640:1 1641:1 1642:1 1643:1 1644:1 1645:1 1646:1 1647:1  |EV| 
-0.85557372333789771801093593239784  |BT| (S (NP (PRP$ (Our))(VBP (result)))(VP (VBP (indicate))(NP (S (NP (NN (miR-9))(NN (miR-197)))(VP (ADVP (RB (specifically)))(VBP (downregulate))(NP (NN (MTHFD1L))(NN (level))(NN (HEK293))(NN (MCF-7))(NN (cell))(NN (SNPrs7646)))(ADVP (RB (significantly)))(VP (VBP (affect))(NP (NP (NN (miR-197))(NN (binding))(NN (affinity))(NN (MTHFD1L))(CD (3)))('' ('))(NN (UTR)))(, (,))(S (VP (VBG (causing))(NP (NP (JJ (efficient))(JJ (posttranscriptional))(NN (gene))(NN (repression))(NN (presence))(NN (allele)))(VP (VBN (associated)))))))))(NP (VBD (increased))(NN (risk))(NNS (NTDs)))))) |ET|  |BS| 6:G05.360.340.024.340 61:E05.318.740.600.800 77:G05.360.340.024.340.030 208:F01.393.821 252:F02.784.692.351 411:C10.500.680 431:D13.444.735.544.875 432:A11.251.210.190.630 433:F01.470.047  |ES| 2:1 9:1 19:1 47:1 94:1 101:1 124:1 169:1 171:1 230:1 249:1 346:1 508:1 658:1 706:1 862:1 1279:1 1398:1 1479:1 1480:1 1481:1 1482:1 1483:1 1484:1 1485:1 1486:1 1487:1 1488:1 1489:1 1490:1 1491:1 1492:1 1493:1  |EV| 
